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Macromolecules, due to their large size and complexity are prone to a variety 
of physical and chemical degradations. Development of stable formulations that 
retain the macromolecule’s stability and activity over its designated shelf life is 
therefore a crucial step in the production of such complexes as safe and effective 
therapeutics. One rapid and systematic formulation tool is the utility of the empirical 
phase diagrams (EPDs) which have enhanced our understanding of the response of 
the structure and stability of proteins to environmental perturbations. In the case of 
more complex macromolecular systems (e.g., multi-domain fusion proteins, large 
recombinant proteins, and viruses), however, the measured stability is presumably the 
sum of all components. This makes interpretations at the molecular level difficult. 
Herein, we have investigated the structural stability of three macromolecular systems 
of varying complexity to see if their structural stability can at lest be partially 
understood in terms of the behavior of their individual domains and components. We 
have examined the effect of the observed structural alterations on the losses in 
activity. We have discussed how this information can be used in designing high 
throughput screening assays for identification of solution stabilizers for developm nt 
of optimal formulations. The utility of the obtained information in interpretation of 
the biological functions of these systems in vivo is also evaluated.   
 iv
Furthermore, EPDs constructed based on techniques sensitive to transitions 
due to alterations of protein motions have been shown to provide information above 
and beyond that obtained by the static approach. Therefore, integration of techniques 
that detect extensive and subtle conformational alterations of proteins, as well
structural fluctuations into an EPD appears to be crucial. Herein, we show that plots 
of the temperature dependent 2nd derivative peak positions of aromatic residues have 
measurable slopes prior to protein unfolding and that these slopes are sensitive to the 
dielectric properties of the surrounding microenvironment. We show that such data 
hold valuable information regarding protein dynamic fluctuations that can be 
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1.1.  Overview 
Due to their large size and complexity, macromolecular-based therapeutics are 
prone to a variety of different physical and chemical degradations often leading to 
loss of their biological activity and altered immunogenicity1. Physical degradation 
primarily occurs due to protein structural changes, aggregation, and undesired 
adsorption to surfaces while chemical degradation refers to modification of covalent 
bonds such as oxidation, deamidation, and disulfide bond shuffling2. Both 
degradation pathways may occur simultaneously during different stages of 
manufacturing, storage, and shipment of protein drugs, introducing significant 
difficulties in their development into safe and efficacious therapeutics. Retaining 
storage stability is often a major challenge and a bottleneck in protein development 
due to the commonly required long protein shelf lives of 18-24 months3.  
Given the high degree of structural complexity and associated degradation 
pathways, a robust formulation (liquid or lyophilized) that retains the protein’s 
stability and activity over its entire shelf life is essential. The FDA requires that the 
stability and activity of potential protein therapeutics be demonstrated in real tim  
under the proposed labeled storage conditions. Considering the long protein shelf life, 
however, these types of studies demand significant resources be dedicated to them for
extended periods of time. One time and cost effective approach is to conduct 
accelerated stability studies to screen for potential formulations with properties that 
lead to enhanced stability under more moderate storage conditions. Such accelerated 
studies are typically conducted under a variety of different stressed conditions (e.g., 
 - 3 -
elevated temperatures, suboptimal pH, high or low ionic strengths, etc.) to facilitate 
protein degradation in a short period of time. Herein, we have employed a rapid and 
systematic approach for biophysical characterization of complex macromolecular 
systems under accelerated degradation conditions. This approach, referred to as the 
“Empirical phase diagram” (EPD approach) utilizes advanced algebraic procedures to 
integrate a large library of data obtained from a variety of biophysical te hniques into 
an easy-to-interpret color coded map to provide a global picture of protein structural 
alterations under a wide range of solution conditions.  
Employing this approach, we have characterized the stability of three complex 
macromolecular systems; a large recombinant ribonucleoprotein (chapter 2), a novel 
multi-domain fusion cytotoxin (chapter 3), and a live-attenuated double stranded 
RNA virus (chapter 4). We not only demonstrate the ability of this approach to 
provide a thorough in vitro characterization of such complex macromolecular systems 
but we also discuss the details obtained from such analyses that could be used to 
interpret the biological function of these systems in vivo. In certain cases, we use 
complementary techniques such as electron microscopy imaging and activity assays 
to further explain the importance of the structural transitions associated with such 
complex systems and highlight the biological significance and physiological 
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1.2. Biophysical Characterization of Macromolecules 
Development of a stable formulation that retains protein stability over its 
designated shelf life is a crucial step in the production of such complexes as safe nd 
effective therapeutics. Rigorous design of such formulations requires an 
understanding of the macromolecule’s behavior under a variety of stressed solution 
conditions. Demanding structural stability for proper functioning of protein 
therapeutics and optimization of conditions that maintain and/or enhance the stability 
of macromolecules is the main objective of pre-formulation studies. The informatin 
obtained from the EPD approach serves such a purpose by providing a basis for the 
development of high-throughput excipient screening assays due to its utility in 
identification of boundary regions over which degradation pathways are accelerated. 
Empirical phase diagrams as will be described in more detail later in this chapter are 
constructed based on a variety of biophysical (i.e., often spectroscopic and 
calorimetric) techniques, a few of which are frequently used in these investigations 
are described below.   
 
1.2.1. Circular Dichroism 
Normal absorption spectroscopy of electronic transitions is measured as 
absorbance, A, according to Beer-Lambert law: 
A = Log10 (I0/I) = εcl 
Where A is the measured absorbance signal, l is the length of thelight pass, ε is the 
molar extinction coefficient, c is concentration, and I0 and I are the intensity of the 
 - 5 -
incident and transmitted light respectively. Circular dichroism i  a variation of 
electronic absorption spectroscopy that uses circularly polarized lght rather than 
normal isotropic light and is defined as the difference in absorption of the left and 



























Figure 1.1.The CD spectra for the α-helix (solid line), β-sheet (dots and dashes), β-
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The amide bond of the peptide backbone is the main chromophore used when 
analyzing CD signals due to sensitivity to various types of protein secondary structure. 
Different protein secondary structural elements exhibit distinct spectra in the range of 
190-260 nm. For example, α-helices exhibit a strong double minima at 222 and 208-
210 nm and a stronger maximum at 191-193 nm. β-sheet structures typically manifest 
a weaker single minimum between 215 and 217 nm and a stronger positive max mu  
between 195 and 200 nm5. Figure 1.1 shows distinct CD spectra of a variety of key 
secondary structural elements with α-helix (solid line), β-sheet (dots and dashes), β-
turn (dotted line), and random coil (dashed line) illustrated. Alterations of protein 
secondary structure as a function of a variety of stressed solution variables can 
therefore be studied by monitoring changes in CD signals with often a loss of signal 
intensities or distortion of spectra and shifts in peak position as i dicative of protein 
secondary structural alterations.  
 
1.2.2. Intrinsic Fluorescence Spectroscopy  
Intrinsic fluorescence spectroscopy is often used to study protein tert ary 
structural alterations. The three aromatic amino acids phenylala ine, tyrosine, and 
tryptophan all can contribute to protein fluorescence spectra. Phenylalanine has a very 
low quantum yield of ~ 0.03 and does not contribute significantly under most 
conditions. If excited below 270 nm, it exhibits a weak emission peak at ~ 282 nm if 
it is not obscured by the emission of tyrosine and tryptophan. Tyrosine has a quantum 
yield of ~ 0.14 (very close to that of tryptophan with a value of ~ 0.13) exhibiting an 
 - 8 -
emission maximum at ~ 303 nm. Unlike tryptophan, however, the emission pectra of 
both phenylalanine and tyrosine are rather insensitive to the polarity of their 
surrounding environment. Free tryptophan manifests an emission peak at longer 
wavelengths at 350-355 nm, and is very sensitive to solvent polarity. It accounts for 
most of a protein’s fluorescence with excitation wavelengths above 290 nm6. The 
emission spectra of indole can reveal the location of the tryptophan residue in protein 
since the emission from an exposed tryptophan residue occurs at higher wavelengths 
than that of a buried one. Monitoring of such emission maxima is therefor  utilized in 
studies of protein conformational alterations. Upon unfolding of proteins, the 
tryptophan residues become exposed to the polar solvent, resulting in shifts of their 
emission maximum to higher wavelengths (i.e., red shifts). On the other hand, the 
burial of tryptophan residues due to the protein fold or from oligomerization or 
aggregation can cause blue shifts in the emission maximum.  
The presence of multiple tryptophans, such as is often the case for complex 
macromolecular systems such as those examined here, can complicate the 
quantitative interpretation of the intrinsic fluorescence data since th  
microenvironment of each tryptophan residue is distinct but the emission of different 
tryptophan residues extensively overlap. This makes it impossible to sparate the 
contribution of each individual residue. Although quantitative analyses of uch 
systems appears to be information poor, qualitative studies based on the average peak 
shifts from a collective number of tryptophan residues are indicative of protein 
conformational alterations.   
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It is also possible to monitor light scattering data simultaneously with 
emission data by monitoring the scattered light seen at the excitation wavelength. 
This can be most easily achieved through the use of a second photomultiplier located 
at 180o to the fluorescence detector. Increases in scattering signals are often indicative 
of aggregation or the presence of some form of higher order species contributing 
significantly to the scattered signals observed. Decreases re also seen due to the 
decrease in scattering produced by product of reduced refractive index.     
 
1.2.3. Extrinsic Fluorescence Spectroscopy  
In addition to the naturally occurring tryptophan chromophore, a variety of 
extrinsic probes can also be used to monitor protein structural alterations due to the 
sensitivity of their emission bands to the polarity of the surrounding 
microenvironments. The most commonly used extrinsic probe in protein unfolding 
studies is 8-anilino-1-naphthalenesulfonate (ANS). The fluorescence of the 
hydrophobic probe ANS is highly quenched in aqueous solution. It, however, exhibits 
strong fluorescence in less polar environments. Upon protein structural alterations, 
ANS may bind to exposed apolar patches on proteins causing blue shifts of its 
emission maximum and an increase in its fluorescence intensity7,8. Caution should be 
taken in interpretation of such data, however, since interaction between the negatively 
charged sulfonate group of ANS and positively charged residues on the protein can 
contribute to alterations of the ANS fluorescence signals observed7,8.  
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Other types of extrinsic fluorescence probes are also commonly employed. 
For example, Thioflavin T and Congo red (CR) have been shown to bind to protein 
structures rich in intermolecular β-sheet content. Therefore, these dyes have been 
used as a tool for detection of amyloidogenesis during amyloid fibril formation in 
Alzheimer’s disease9,10. Congo red selectively binds to proteins with extended 
intermolecular β-sheet conformations, a defining characteristic of amyloid fibrils. 
Inouye et al. have shown that binding of Congo red to amyloid fibrils occurs through 
both ionic and non-ionic processes. In the former, the negatively charged sulfonate 
groups of CR bind to positively charged histidine residues in a protein, and therefore, 
is a pH dependent event. The latter was proposed to be due to van der Waals 
interactions of the dye π system with the peptide9,10. Other macromolecules such as 
RNA-polymerase11, dehydrogenases12, cellulose13, elastin14, chitin15, and HIV-1 
protease16 also bind to Congo red, making it an effective tool for the study of their 
conformational alterations.  
Thioflavin T (ThT) extinction coefficient and the position of its long 
wavelength absorption band depend on solvent polarity17. Monitoring ThT 
absorbance in a series of water-glycerol mixtures shows red shifts of the lng 
wavelength absorption band of ThT from 412 nm in water to 421 nm in 99% glycerol. 
The fibril-bound ThT exhibits a long-wavelength absorption band at ~ 450 nm, 
significantly red shifted compared to its position in water; therefore, it can be used to 
detect fibril formation, or perhaps other structures with highly rich β-s eet content.  
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1.2.4. Dynamic Light Scattering 
Dynamic light scattering is a useful technique for determining the 
hydrodynamic size of the particles. Particles undergo Brownian motion in solution 
and therefore change their relative position as a function of time. Smaller particles 
diffuse quickly, generating scattering signals that fluctuate r pidly. Larger particles 
generate signals that fluctuate more slowly. The time dependence of these 
fluctuations can be characterized by an intensity autocorrelation function which is a 
function of the diffusion coefficient. This allows direct measurements of the latter. 
Assuming a uniform spherical shape for the particles, the Stokes-Einstein equation is 
then used for calculations of the hydrodynamic radius (Rh) based on the 
experimentally determined diffusion coefficient (DT): 
Rh = kB.T / 6πηDT 
In which kB is the Boltzman constant, T is the absolute temperature, and η is the 
solvent viscosity. The calculation of the Rh can be carried out using commercially 
available software packages equipped with multiple analyses tools. A common 
approach is the method of cumulants which is based on a polynomial fit to the log of 
the autocorrelation function18. For narrow size distributions, the autocorrelation 
function is adequately analyzed by the method of cumulants. For polydisperse or 
multimodal size distributions, however, the data analysis is much more complex19. 
The hydrodynamic diameter can also be calculated in a multi-size distribution (MSD) 
mode, using a non-negatively constrained least square (NNLS) algorithm in which the 
autocorrelation function is deconvoluted, generating resolved values comparable to 
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the actual particle size19. The choice of the analysis method depends on the nature and 
heterogeneity of the macromolecular system examined.  
As mentioned previously, the Stokes-Einstein equation assumes spherical 
particles and therefore deviations in shape (e.g., rod shape particles) could introduce 
significant deviations in obtaining the absolute size of the particles n solution. This 
technique, however, can be used qualitatively in studies of protein self-as ociation 
and aggregation in which such processes often result in an increase in average particle 
size as observed by this technique. Employing the MSD approach involving 
deconvolution of multi-size distributions provides a very powerful quantitative tool in 
detection of very small amounts (less than a percent) of higher ord  species (i.e., 
dimers, tetramers, etc.) as well as aggregates since small amount of larger size 
particles scatter light more effectively than a large amount of smaller siz  particles.         
 
1.3. Construction of Empirical Phase Diagrams  
A variety of biophysical techniques such as those described above, each 
sensitive to a certain structural feature of a protein, are used to obtain a complete 
picture of protein behavior. One of the potential drawbacks is that the interpretation 
of such large and complex data sets can be quite difficult. Therefore, integration of 
such large data sets into a unified picture is beneficial by providing the 
pharmaceutical scientist the opportunity to predict the state of the protein under all 
conditions of interest. An empirical phase diagram (EPD), based on a combination of 
a large data set provides an easy analysis by following the color-mapped image of a 
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protein’s global behavior under a wide range of solution conditions. Employing such 
an approach, a macromolecule or its complexes can be represented by a vector in a 
highly dimensioned experimental space. The vector varies as a function of alteration 
in solution parameters such as pH, temperature, ionic strength, and macromolecule 
concentrations. 
In brief, the macromolecule is represented as an n dimensional vector in an 
experimental space in which the n dimensions are constructed at any two 
combinations of stress conditions (i.e., pH, temperature, ionic strength, protein 
concentration, etc.); n refers to the number of different data sets collected (i. ., CD 
intensity, Trp peak position, ANS intensity, hydrodynamic diameter, c.). 
Experimental data at each combination of stress variables (e.g., pH/ temperature) 
serve as one component of an n dimensional vector. The data is normalized between  
-1 and 1 and are integrated into an n x n density matrix containing all the individual 
vectors. The n sets of eigenvalues and eigenvactors of the density matrix are 
calculated, and the three largest eigenvectors corresponding to the three largest 
eigenvalues are identified. The density matrix is then truncated and re-expanded into 
three dimensions with the three largest sets of eigenvectors corresponding to its basis. 
The resultant three dimensional vectors are then converted into a color-coded map in 
which each vector corresponds to a color using an arbitrary red/green/blue (RGB) 
color system. All calculations are performed using Matlab software (Th MathWorks, 
Natick, MA). Details of the mathematical theory and calculation process can be found 
elsewhere20.   
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Empirical phase diagrams can be constructed based on a single or multiple 
techniques. The first successfully utilized EPD was generated based on the single 
technique of second derivative absorbance peak positions of these aromatic esidues20. 
Derivative analysis was used to deconvolute the raw data into multiple high 
resolution absorption peaks that could be used as semi-independent data sets in the 
EPD. In this case, integration of such data sets into an EPD is highly informative due 
to dispersion of the three aromatic residues throughout protein three dimensional 
structures and the high sensitivity of the derivative absorption peak positions to 
alterations in the surrounding microenvironment.  Phenylalanine residues are often 
buried in the core of proteins while tyrosines are interfacial and tryptophan residues 
are more widely dispersed. Employing this approach provides a global picture of a 
protein’s behavior in solution.  
The EPD approach has been successfully employed to examine a wide variety 
of macromolecular entities including peptides, proteins, recombinant protein based 
vaccines, viruses and virus like particle (VLP) based vaccines, DNA, bacterial 
vaccines, and gene delivery vectors20-35. Employing multiple techniques provides a 
more detailed picture by integration of more independent data sets, each sensitive to a 
certain feature of protein structure. As implemented in the three case studies 
presented in this thesis, a combination of circular dichroism, intrinsic and extrinsic 
fluorescence, and static and dynamic light scattering techniques generates an EPD 
reflecting protein secondary, tertiary, and quaternary structural alterations as well as 
aggregation tendencies. In either case, when analyzing an EPD, regions of continuous 
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color define distinct physical states of the macromolecular system under the stress 
conditions investigated. Abrupt changes in color, however, are indicative of some 
form of protein structural alteration and correspond to transitions between various 
physical states of the macromolecule. It should also be emphasized that empirical 
phase diagrams are not thermodynamic phase diagrams in which equilibrium exists 
between different phases. At least partially irreversible aggregation or conformational 
change prevents any equilibrium among different phases.  
 
1.4. High Throughput Screening Assays  
The abrupt changes in color in the EPD represent apparent phase boundaries 
over which protein shows marginal stability. High throughput screening assays to 
identify potential stabilizer(s) of macromolecules can therefore be developed over 
such regions in which protein degradation is accelerated. A large library of potential 
excipients is screened and more promising stabilizers are identified. The compounds 
tested are preferably selected from a large library of GRAS (Generally Regarded as 
Safe) stabilizers approved by the FDA for therapeutic use. Non-GRAS stabilizers 
such as polyanions and other low molecular weight di- and multi-ions are also 
screened. Although applications of the latter are not yet used in FDA approved 
protein-based drug formulations, studying the mechanisms by which tey affect 
protein stability provides insight into protein stabilization strategies. Examined 
excipients are often tested over a reasonable range of concentration (e.g., 1-20%) and 
in triplicate to ensure reproducibility of the results. Identification of such apparent 
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phase boundaries then serves as a basis for development of high throughput screening 
assays to identify potential stabilizers. 
A rational high-throughput screening assay is often developed as the first step 
of multi-iterative optimization of protein formulation. The preliminary screening step 
usually monitors macromolecule aggregation kinetics in which the inhibitory effect of 
a given excipient on protein aggregation is examined as a function of time over some 
marginally stable condition identified in the EPD (e.g., extremes of pH and elevated 
temperatures). In the second stage, stabilizers that show early promise as aggregation 
inhibitors are then examined further over a wider range of concentrations as well  in 
combination with other promising excipients to see if there is an additive or 
synergistic stabilizing effect of these compounds. Optimization of the selected 
excipients is then verified in stage three by testing their ability to stabilize protein 
conformation. This step is crucial since not all excipients which are effective 
inhibitors of protein aggregation necessarily stabilize its conformation. This is 
observed in these studies on the fusion cytotoxin (see chapter 3) in which polyanions 
extensively inhibit aggregation of the protein but lead to significat destabilization of 
its tertiary structure. In this last step, a protein’s apparent thermal transition 
temperature(s) (Tm) in the presence and absence of excipients is determined where an 
effective excipient results in shifting of the Tm values to higher temperatures. The 
stabilizer combination and their final concentrations are further optimized to provide 
a suitable liquid formulation that is compatible with the macromolecule’s therapeutic 
application and its route of administration. In addition, the ionic strength, osmolarity, 
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and viscosity of the protein formulation are also adjusted as a reult of presence of 
such excipients.  
Although such accelerated stability studies provide a rapid and systematic 
approach for identification of potential stable protein formulations under artifici lly 
induced degradation conditions, the true ability of such formulations to provide real 
time stability should be further examined in actual long-term stability studie. This is 
due to the possible presence of different degradation mechanisms under accelerated 
versus more moderate storage conditions36. The chemical stability and biological 
activity of potential formulations from preliminary accelerated studies should be 
tested to ensure that there is no degradation of the protein or the additives as well as 
no undesired effects of the excipients on the biological activity of the protein during 
long term storage. The high throughput screening approach described here has been 
successfully used for the formulation of a variety of macromolecules such as peptides, 
proteins, viruses, and virus like particles1,37-39.  
 
1.5. Protein Dynamics 
In the past, proteins were often perceived as relatively static structures based 
on their X-ray analysis. It is now well accepted, however, that proteins are highly 
dynamic molecules exhibiting a wide variety of different types of motions in wh ch 
both their static and dynamic properties as well as the nature of the surrounding 
environment affects their structure and function. Central questions as to how protein 
dynamics affect their structure and function, and how environmental factors affect 
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protein dynamical-structural-functional properties have engendered great interest. 
Various protein functions such as substrate binding, product release, regulation, 
allosteric behavior, as well as contractile and motor functions are heavily controlled 
by collective motions within proteins40. Fluctuations of the surrounding solvent 
molecules have been shown to control protein dynamic motions, engendering the use 
of the term “slaving” to describe the significance of the dominant role of solvent in 
controlling protein dynamics and function41.  
The relationship between protein dynamics and stability, although still 
somewhat unclear, is a point of great interest with extensive studies linking the two42. 
Such studies suggest that analyses of protein flexibility along with its static properties 
are necessary for successful characterization of protein structural stability. Therefore, 
the availability of techniques that detect extensive and subtle conformational 
alterations of proteins, as well as structural fluctuations appears to be crucial. Herein, 
we have presented the EPD approach based on a variety of biophysical techniques 
that are sensitive to conformational alterations and aggregation (i.e., static properties) 
of macromolecules. A variety of biophysical methods have been used to measure 
various aspects of protein structure from which dynamic behavior can be inferr d. 
These techniques include isotope (H/D) exchange monitored by infrared spectroscopy, 
mass spectrometry, and nuclear magnetic resonance (NMR) spectroscopy a well as 
other methods such as red edge shift spectroscopy, solute fluorescence quenching, 
ultrasonic spectroscopy, pressure perturbation calorimetry and molecular dynamics 
simulations42.  
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Recent efforts have employed data from spectroscopic techniques sensitive to 
protein dynamic properties for construction of empirical phase diagrams sensitive to 
transitions due to alterations of protein motions. Such a dynamic-based approach 
revealed that dynamic EPDs provide information above and beyond that obtained by 
the static approach43. As part of efforts to utilize available spectroscopic tools in a
better understanding of protein dynamic properties, for the first time we here examine 
the utility of the temperature dependent UV absorption spectroscopy of aromatic 
residues in protein pre-transition regions to show that information obtained from such 
analyses hold valuable information regarding protein dynamic fluctuations. Details 
will be found in chapter 5 but here a brief overview of UV absorption spectroscopy of 
proteins is presented. 
 
1.5.1. Ultraviolet Absorption Spectroscopy of Proteins 
 
1.5.1.1. Protein Intrinsic Chromophores  
Proteins display a broad peak in the 250-300 nm region of their ultraviolet 
spectrum composed of multiple overlapping bands from the aromatic residues 
phenylalanine, tyrosine, and tryptophan. These peaks are due primarily to π → π*
transitions involving the electrons of their aromatic rings44. The indole side chain of 
tryptophan absorbs strongly (ε280nm = 5540) with a maximum peak at ~ 280 nm and a 
less intense transition, usually observed as a shoulder at ~ 292 nm. Alterations of 
tryptophan absorption spectra could occur due to oxidation of the indole moiety, 
which contributes to the change in the wavelength45,46. The absorption of tyrosine is 
less intense (ε280nm = 1480) with maximum absorbance at ~ 276 nm and two small 
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shoulders. Tyrosine is even more susceptible to structural modifications with the 
phenol side chain susceptible to ionization47, iodination48, chlorination48, and 
oxidation46. Finally, the phenylalanine side chain, benzene, exhibits the weakest 
transition (ε258nm = 197) in the 250-270 nm range, usually appearing as multiple subtle 
inflection points (i.e., bumps) in the near-UV region with a peak center at ~ 260 nm. 
When analyzing the zero-order spectra, phenylalanine weak absorbance is often
obscured in the presence of tyrosine and tryptophan residues demanding derivative 
analysis for recognition of its contribution. 
The most common chromophore of proteins is perhaps the amide group of the 
peptide backbone. It contains two major transitions with the first strongly absorbing 
at 195 nm (π→π*) and a second weaker transition occurring at ~ 220 nm (n→π*). 
With α-helix, β-sheet, and random coil structures each exhibiting distinct absorbance 
characteristics in the far UV region, the peptide group was in the past used to stu y 
protein secondary structure49. The associated data interpretation is, however, difficult 
due to interferences by inorganic ions and dissolved oxygen absorbing below 200 
nm48 and requires purging of spectrophotometers with nitrogen. Availability of other
sensitive techniques (e.g., circular dichroism and FTIR spectroscopy) to protein 
secondary structural alterations has also shifted the utility of the ultravio et absorption 
spectroscopy to studies of protein tertiary structure in the 250-300 nm region where 
the aromatic residues show distinct absorbance characteristics.   
A non-aromatic amino acid contributing appreciably in the 250-300 nm region 
of the protein absorption spectrum is the disulfide-bridge form of cysteine (i.e., 
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cystine)50 and the presence of such should be considered. Other residues such as 
methionine and histidine absorb weakly in the lower wavelength regions but their 
contributions are usually hampered by the much stronger absorption bands of the 
peptide backbone and aromatic side chains48.   
 
1.5.1.2. Data Analysis 
 The application of UV absorption spectroscopy to proteins was initiated more 
than half a century ago by analysis of their “zero order spectra” at relatively low 
resolution51. Zero order spectra represent the raw data collected by the 
spectrophotometer. In the case of protein studies, it typically consists of a str ng
transition below 210 nm from the amide group of the peptide backbone followed by a 
weaker transition in the 250-300 nm region, composed of multiple overlapping bands 
from the aromatic residues phenylalanine, tyrosine, and tryptophan44. As mentioned 
above, the utility of the amide backbone peak has been of limited use due to 
interferences from inorganic ions and dissolved oxygen. It is now well understood, 
however, that peak shifts of the aromatic residues correlate with protein structural 
perturbations due to their sensitivity to the polarity of the local environment of these 
side chains. Until early 80s, the utility of the aromatic residues was quite lim d due 
to the extensive overlap of their absorption peaks and only major structural changes 
such as extensive unfolding events were routinely studied.   
Derivatization of the zero-order data in the 250-300 nm region of the UV 
spectrum resolves the overlapping peaks of phenylalanine, tyrosine, and tryptophan to 
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allow qualitative analysis of the contribution of each residue to the overall protein 
spectrum. The limitations of early spectrophotometers, however, allowed only 
detection of ~1 nm shifts of the absorbance derivative peaks52. Following advances in 
instrumentation, in particular the availability of diode array detectors and 
supplementing the derivative analysis with interpolation algorithms53 the resolution of 
the absorption bands of each of the three aromatic residues were greatly enhanced. 
Our experience shows that resolution as high as 0.01 nm can be obtained when 
employing a nine-data point filter and fifth degree Savitzky-Golay polynomial, 
following by fitting to a cubic function, with 99 interpolated points perraw data point. 
This provides a powerful tool for probing protein conformational alterations by 
monitoring the derivative peak shifts of the aromatic residues as a function of variety 
of stressed conditions. Furthermore, the intensity of these derivative peaks has been 
employed as a quantitative probe of the number of phenylalanine and tryptophan 
residues54, as a measure of Tyr/Trp ratios, and as a qualitative measure of solvent 
polarity surrounding the aromatic side chains55. Because derivative analysis is not 
sensitive to broad spectral components, light-scattering effects do not dramatically 
affect determination of the derivative peak positions56. Figure 1.2 illustrates the high 
resolving power of the derivative analysis (right panel) in which the broad, low 
resolution zero-order absorption peaks of the three aromatic residues (left panel) have 
been deconvoluted to their comprising peaks exhibited as minima in the 2nd d rivative 
plots. 
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Figure 1.2.Zero-order and second derivative absorption spectra of N-acetyl X-ethyl 
ester derivatives of and phenylalanine (PHE), tyrosine (TYR), and tryptophan (TRP). 
The ordinate axis is presented in arbitrary units. 
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1.5.2. Studies of Protein Conformational Alterations (Static Properties) 
With the availability of diode array detectors and employing high resolution 
2nd derivative analysis upplemented with interpolation algorithms, the absorption 
bands of each of the three aromatic residues can be deconvoluted with a resolution of 
approximately 0.01 nm. This provides a very sensitive tool with which to probe 
protein conformational alterations in which the polarity of the microenvironment 
surrounding the aromatic side chains and their level of exposure to solvent are 
detectably altered upon protein structural changes. Therefore, by monitoring the 
individual shifts of the derivative peak position of these residues, fairly detailed 
information can be obtained regarding the conformational alterations of proteins as a 
function of variety of solution conditions such as pH, temperature, ionic strength, 
presence of additives, etc. In general, peak shifts to lower wavelengths (i.e., blue 
shifts) are indicative of the aromatic side chains exposure to a more polar solvent 
environment whereas shifts to longer wavelengths (i.e., red shifts) manifest burial of 
these residues. Employing this technique, shifts as small as 0.1 nm and as large as 6 
nm have been correlated with protein structural alterations57,58. 
 
1.5.3. Studies of Protein Dynamic Properties  
Recent efforts have attempted to extend the utility of the 2nd derivative UV 
absorbance spectroscopy of the aromatic residues beyond protein static studies in o 
the world of protein dynamics. This initial work was initiated by examination of the 
pioneering idea of monitoring cation interactions with the π systems of the aromatic 
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side chains employing high resolution 2nd derivative UV absorbance spectroscopy. By 
analogy to solute-based fluorescence quenching of proteins, Lucas et al. performed 
UV-spectroscopy dynamic-based analyses by employing the spectral shifts induced 
by cation (Na+, Li+, Cs+)-π interactions as a function of increasing cation 
concentration45. Small cations were found to be more effective at inducing spectral 
shifts due to their ability to diffuse through a protein’s matrix and make contact wi h 
the aromatic side chains. In some cases, interpretation of dynamic effects was, 
however, difficult due to specific interactions between the cations (and perhaps 
accompanying counter anions, Cl-) with the proteins44. Thus, a method that does not 
require the presence of potentially perturbing solutes, but rather involves a simple
intrinsic effect such as temperature seems desirable. This is the motivation for the 
studies presented in chapter 5 on the origin of the temperature dependent 2nd 
derivative peak shifts of the aromatic residues and integration of such information to 
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2.1. Introduction 
Some twenty years ago, Kedersha and Rome purified a large 
ribonucleoprotein particle from rat liver homogenates and named it the “vault” 
particle on the basis of its morphological resemblance to vaulted ceilings in medieval 
cathedrals.1-2 Cryoelectron microscopy (CryoEM) single particle reconstructions and 
X-ray crystallography show vaults to posses a hollow, barrel-like structure with two 
protruding caps and an invaginated waist.3-4 With a molecular weight of 12.9±1 MDa 
and dimensions of ~ 420 x 420 x 750 Aº, vaults are the largest ribonucleoproteins 
known.2 Conservation of vaults among eukaryotes as diverse as mammals, 
amphibians, avians, sea urchins, and slime molds5 points to an important functional 
role for these unique particles. Although the natural function of the vault complex is 
still unclear, their morphology and subcellular localization suggest some type of rol  
in intracellular (e.g., nucleocytoplasmic) transport.6 The presence of these particles 
has also been linked to multidrug resistance in tumor cells since high level expression 
of the major vault protein is observed in certain transformed cell lines that are 
resistant to xenobiotics.7-10 In addition, vaults may play a role in scaffolding different 
cell signaling pathways11 and in protection against some forms of infectious disease.12   
Vaults are composed of multiple copies of three proteins: 96 copies of the 97 
kDa major vault protein (MVP), which accounts for more than 70% of the particle 
mass, 2 copies of the 290 kDa telomerase-associated protein 1 (TEP1) and 8 copies of 
the 193 kDa poly (ADP ribose) polymerase (VPARP). In addition, at least 6 copies of 
an untranslated small RNA (vRNA) are present.10 The potential functions of vault 
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proteins 2, 10,13 and their interactions with one another are discussed in detail 
elsewhere.6,11  
In vitro, expression of MVP alone in Sf9 insect cells employing a bac-to-bac 
baculovirus expression system results in the production of recombinant particles with 
the characteristic vault morphology.5,13 The most reproducible form of recombinant 
vaults and the model system employed in this study is the Cys-rich tagged (CP-MVP) 
vault which contains 96 copies of the major vault protein modified at the N-terminus 
with a 12 amino acid peptide tag (MAGCGCPCGCGA) from the metal binding 
protein, metallothionine.14 The CP-MVP form of vaults has been used to generate 
high resolution CryoEM images (16 Aº) and appears to be more stable than other 
recombinant forms, presumably due to the Cys residues of the tag forming disulfide 
bridges at the vault’s waist, stabilizing the overall vault’s structure.14  
Recent findings concerning the dynamic structure of the vault exterior shell15 
and dissociation of the vault particle into halves at low pH14 along with successful 
attempts to target and sequester biologically active materials within the vault cavity3 
have engendered interest in employing recombinant vaults as nanocapsules for the 
delivery of biomolecules. Since one of the major issues facing the field of 
bionanotechnology is cellular compatibility, using the cell compatible, naturally 
occurring vault nanocapsules as drug delivery devices could potentially have unique 
therapeutic applications.  
Characterization of the physical stability of vault particles under a variety of 
solution conditions has the potential to provide important information concerning 
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vault’s structural integrity and their potential use as drug delivery vehicles. With this 
goal in mind, we have subjected recombinant vaults to a wide range of pH and 
temperature employing a variety of spectroscopic techniques and electron mic scopy 
(EM). This data has been integrated into an empirical phase diagram (EPD) to 
provide a global view of vault’s secondary and tertiary conformational alterations 
over a wide range of experimental conditions.16-17  
 
2.2. Materials and Methods 
2.2.1. Vault Purification  
Recombinant vaults formed from CP-MVP were purified from baculovirus 
infected Sf9 cells, as previously described.5,13 A 12-residue cysteine rich motif 
(MAGCGCPCGCGA) on the N-terminus of CP-MVP was previously shown to help 
stabilize the recombinant vaults.4,13 Purified vault particles were resuspended in 20 
mM citrate-phosphate buffer pH 6.5.  
 
2.2.2. Sample Preparation  
Vault solutions at different pH values were prepared in 20 mM isotonic 
citrate/phosphate buffer by dialyzing stock solutions into buffers ranging from pH 3 
to 8, at one unit pH intervals. The isotinicity was maintained using sodium chloride. 
For buffer exchange, vault samples were dialyzed at refrigerator temperatures using 
Slide-A-Lyzer® Dialysis Cassettes, 10 kDa MWCO (Pierce, Rockford, IL). Vault 
solutions were studied at a concentration of 100 µg/ml with the exception of ANS 
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fluorescence studies where 50 µg/ml vault samples were used. The concentrations of 




14 Three independent samples were evaluated to ensure 
reproducibility of the measurements.  
 
2.2.3. Transmission Electron Microscopy  
Transmission electron microscopy of uranyl acetate-stained vaults was carried 
out to analyze structural alterations due to changes in pH and/or temperature. Briefly, 
purified vaults (0.5-1 mg/ml) were dialyzed into isotonic 20 mM citrate phosphate 
buffer at pH 3, 5, 6, or 8 for about 16 h at 4 °C. The dialyzed vaults were recovered 
and conformational changes were analyzed under variable temperatures by negatively 
staining with uranyl acetate and viewed with a JEM1200-EX transmission electron 
microscope (JEOL, Tokyo, Japan). Vault samples were absorbed onto carbon coated 
grids and after incubating for 5 min at the appropriate temperature and pH, the EM 
grids with absorbed vaults were blotted on filter paper and floated on 1% uranyl 
acetate at the appropriate temperature for staining. They were then blottd and dried 
on filter paper. TEM images were captured with a BioScan 600W digital camera 
(Gatan Inc., Pleasanton, CA) using Gatan’s DigitalMicrograph (version 3.7.1).  
 
2.2.4. Far-UV Circular Dichroism (CD) Spectroscopy  
CD spectra were acquired using a Jasco J-810 spectropolarimeter equipped 
with a 6-position Peltier temperature controller. The CD spectra were obtained from 
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260-190 nm with a scanning speed of 20 nm/min, a 2 sec response time and an 
accumulation of 3. To study thermal transitions (melting curves) of the vaults, the CD 
signal at 222 nm was monitored in 0.1 cm pathlength cuvettes every 0.5 °C over a 10 
to 85 °C temperature range employing a temperature ramp of 15 °C/hr.  
 
2.2.5. Intrinsic Tryptophan (Trp) Fluorescence Spectroscopy  
Fluorescence spectra were acquired using a Photon Technology International 
(PTI) spectrofluorometer (Lawrenceville, NJ) equipped with a turreted 4-position 
Peltier-controlled cell holder. An excitation wavelength of 295 nm was used to 
primarily excite Trp residues and the emission spectra were collected from 310 to 400 
nm with a step size of 1 nm and a 1 sec integration time. Excitation slits were varied 
over the pH range examined from 3 to 5 nm. Light scattering was also monitored at 
295 nm using a separate photomultiplier placed at 180º to the fluorescence detector. 
Both the fluorescence intensity and light scattering data were normalized with respect 
to the initial reading at 10 °C to permit direct comparison of the data. Emission 
spectra employing 4 nm slit widths were collected every 2.5 °C with a 3 min 
equilibration time over a temperature range of 10 to 85 °C. A buffer baseline was 
subtracted from each raw emission spectrum.  
Peak positions of the emission spectra were obtained from polynomial fits 
using Origin software using a “center of spectral mass” method.  Due to the natur of 
center of spectral mass analysis, the reported emission peak position values do not 
correspond to the actual peak positions, but do accurately reflect the changes.  The 
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actual peak positions determined by derivative analysis of the native protein are 
shifted approximately 10-14 nm from their center of mass values. 
 
2.2.6. ANS Fluorescence Spectroscopy 
Accessibility of apolar sites on vaults monitored by fluorescence emission of 
the extrinsic probe 8-Anilino-1-naphthalene sulfonate (ANS). Each sample contained 
a 10-fold molar excess of ANS to vault, an optimal ratio determined in preliminary 
experiments. The ANS was excited at 385 nm and emission spectra were collected 
from 425-550 nm with a step size of 1 nm and 1 sec integration time. Emission 
spectra were collected every 2.5 °C with 3 min of equilibration over a temperature 
range of 10 to 85 °C. Both excitation and emission slits were varied over the pH 
range examined from 6 nm for pH 3 and 4 to 9 nm for pH 5-8; the intensity is 
quantitatively dependent on the excitation source intensity, which is controlled by the
amount of light passed through the slits. The more open the slits, the higher the 
excitation source intensity and therefore the higher the fluorescence intensity. Thus, 
data were normalized with respect to the initial reading at 10 °C to permit direct 
comparison. The ANS-buffer baseline containing almost no fluorescence at each 
corresponding pH was subtracted from raw emission spectra.  
 
2.2.7. Empirical Phase Diagram (EPD)  
Empirical phase diagrams were constructed employing CD mean residue 
ellipticity, intrinsic Trp fluorescence peak position and intensity, tatic light scattering, 
 - 39 -
and ANS fluorescence intensity data. All calculations were performed using Matlab 
software (The MathWorks, Natick, MA). In brief, the normalized experimental data 
at each coordinate (i.e., at a specific temperature and pH combinations) are first 
converted into an N-dimensional vector, where N refers to the number of variables 
included (i.e., number of different types of data). The complex data sets from all 
measurements are now defined as multi-dimensional vectors sitting in a 
temperature/pH phase space. Projectors of each individual vectors are then calculated 
and summed into an N × N density matrix. By definition, an N × N matrix has N sets 
of eigenvalues and eigenvectors. The individual vectors at each coordinate were 
truncated into 3-dimensional vectors and re-expanded into a new basis set consisting 
of the three eigenvectors corresponding to the three largest eigenvalues. The resultant 
3-dimensional vectors were then converted into a color plot with each vector 
component corresponding to a color using an arbitrary RGB (red, green, blue) color 




2.3.1. Far-UV Circular Dichroism (CD) Spectroscopy  
Alterations in vault secondary structure were studied by monitoring the 
changes in the CD signal over a wide range of pH (3 to 8) when subjected to thermal 
gradients from 10 to 90 ºC. The CD signal is expressed in units of mean residue 
ellipticity which are independent of molecular weight, since the average molecular 
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weight of vault particles in solution vary across the pH range due to conformational 
alterations. Using MALLS, Goldsmith et al. showed that the average molecular 
weight of CP-MVP changes from 9.3 MDa at pH 6.5 to ~ 6.7 MDa at pH 3.4.14  
The CD spectra of vaults at 10 °C are highly pH dependent and display 






























































Figure 2.1.CD spectra of Vaults at various pH values. CD spectra were recorded at 
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At pH 3, a broad minimum is observed in the region of 208-225 nm with a 
shoulder at 208 nm, indicative of a mixture of α-helical and β-sheet structures. At pH 
4, a sharp minimum at 225 nm suggests the presence of type II β-turn structure or 
same type of distorted β-sheet. A minimum at 218 nm at pH 5 indicates 
predominantly β-sheet content. Two distinct minima at 208 and 222 nm observed at 
pH 6-8 suggest predominantly α-helical structure in the MVP. Poor quality data 
below 200 nm due to solute interference prevented an unambiguous deconvolution of 
spectra for estimation of secondary structural content.  
Figure 2.2 emphasizes the dramatic effect of temperature on both the loss of 
secondary structure and changes in secondary structural content of the vaults over the 
pH range examined. An overall loss of secondary structure at high temperature is 
observed across the entire pH range; at pH 6, 7, and 8 the secondary structure of the 
vaults goes from predominantly α-helical to β-sheet. This can be explained as due to 
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         Figure 2.2.CD spectra of Vaults at various pH values collected at the indicated    
         temperatures (n=3). 
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Secondary structural alterations of vaults were further studied by CD thermal 
unfolding (Tm) studies in which the mean residue ellipticity at 222 nm was 
continuously monitored upon heating (Fig 2.3). The negative intensity of the CD 
signals at 222 nm decreased significantly upon heating suggesting at least parti l 
unfolding of MVPs. The midpoint of these thermal transitions (Tm) is highly pH 
dependent and in general was found to increase with increasing pH with the exception 
of pH 4 and 5. Thermal transitions occur at ~ 35.6 °C at pH 3, ~ 44.9 °C at pH 4, ~ 
41.2 °C at pH 5, and ~ 56.2 °C at pH 6. (The transition temperatures were determined 
by fitting the data to a non-linear sigmoidal function defined by the Boltzman 
equation). The Tm shifts to higher temperatures at increasing pH suggesting a more 
stable vault assembly at neutral compared to low pH values. The transitions at pH 7
and 8 are very broad, hampering accurate determination of the Tm values. Heating of 
the vaults at the pH extremes of 3 and 8 leads to smaller overall loss as well as more 
complex behavior (Fig 2.3) suggesting additional subtle conformational alterations, 
the presence of folding intermediates, changes in oligomerization state, multiple 
















































Figure 2.3.The effect of temperature on the secondary structure of Vaults at different 
pH values. Mean residue molar ellipticity at 222 nm was measured as a function of 
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2.3.2. Intrinsic Trp Fluorescence Spectroscopy 
Tertiary structure alterations in vaults were studied by monitoring changes i  
the wavelength of the Trp emission peak position and fluorescence intensity as a 
function of pH and temperature (Fig 2.4a and 2.4b, respectively). Initial peak 
positions near 342-343 nm suggest only partial burial (on average) of the indole side 
chains. Trp emission maxima manifest a red shift as the temperature is increased over 
the pH range examined suggesting enhanced exposure of indole side chains to solvent 
upon conformational alterations. Complete unfolding of the vaults at high pH, 
however, seems unlikely due to the small red shifts observed and failure to reach 
emission peak positions above 350 nm.16 The small red shifts at low pH could also 
reflect the presence of half vaults as partially open, structurally altered assemblies.  
The temperature-dependent Trp fluorescence intensity data produced 
estimates of transition temperatures of ~ 45 ºC at pH 4, ~42.5 °C at pH 5, ~50 °C at 
pH 6, ~52.5 °C at pH 7, and ~52.5 °C at pH 8 (Fig.4b) At pH 3, no obvious 























































Figure 2.4.a) Tryptophan emission peak position of vaults as a function of pH and 
temperature. Vault suspensions at pH 3–8 were heated from 10 to 85 °C, and the 
fluorescence emission maxima were determined (=3) after excitation at 295 nm.             
b) Tryptophan emission fluorescence intensity of vaults as a function of pH and 
temperature. Vault suspensions at pH 3–8 were heated from 10 to 85 °C, and the 
fluorescence intensity was monitored (n=3).   
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 2.3.2.1. Static Light Scattering 
 
The aggregation behavior of the vaults was simultaneously examined by 
monitoring the scattered light at the wavelength of excitation (Fig 2.5). The onset of 
aggregation is pH dependent and occurs at ~ 40 °C at pH 3 (please see inset graph in 
Fig 2.5), ~ 40 °C at pH 4, ~ 42.5 °C at pH 5, ~ 48 °C at pH 6, ~ 56 °C at pH 7 and ~ 
63 °C at pH 8. The onset of aggregation is shifted to higher temperatures at increasing 
pH suggesting a more stable vault complex at higher pH in agreement with both the 
CD and intrinsic fluorescence data. 
The decrease in light scattering after the initial increase at the observed 
temperature seen in some cases is presumably due to precipitation of insoluble 
aggregates. This is observed over the pH range of 3-6 with a less intense effect sen 
at pH 3. This phenomenon is not observed at pH 7 and 8 with insoluble aggregates 
not observed at these pH values. Thus, the slight increase in light scattering signal at 
pH 7 and 8 may be due to the formation of soluble oligomers. The aggregation 
behavior of the vaults was further confirmed by optical density measur ments (OD350) 
as a function of pH and temperature (data not shown) in which the OD350 values 
decreased continually over the pH range from 0.26±0.022 at pH 3 to 0.14±0.012 at 
pH 7, again indicating the increasing stability of vault structure as a function of 































































Figure 2.5.Static light scattering as a function of pH and temperature. Vault 
suspensions at pH 3–8 were heated from 10 to 85 °C, and the fluorescence attering 
intensity was monitored at 295 nm (n=3).  
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2.3.3. ANS Fluorescence Spectroscopy  
Alterations in the tertiary structure of vaults were further evaluated in the 
presence of the extrinsic fluorescence probe, 8-Anilino-1-naphthalene sulfonate 
(ANS). The fluorescence of ANS is highly quenched in aqueous solution but can 
increase dramatically in non-polar environments. In addition, the emission maximum 
of the probe is usually blue-shifted upon binding to apolar regions of proteins.16 In 
this experiment, the excitation and emission slit widths were set at 6 nm for pH3 and 
4; 9 nm for pH 5-8 to permit quantitative comparisons. Comparing the absolute 
fluorescence intensity data obtained at 10 ºC (Please see inset graph in Fig 2.6) at low 
and high pH (i.e., pH 3 and 7) generated comparable values of the same order of 
magnitude; Considering the smaller slit widths used for the low pH studies, it can be 
concluded that ANS is increasingly bound to vault complexes at pH 3 compared to 
pH 7 at 10 ºC. This suggests a greater exposure of previously buried apolar regions at 
low compared to high pH. Greater ANS binding may be associated with the presence 
of half vaults and the opening of vault petals into flower-like structures as subunit 
interfaces are exposed.14 
Rat MVP (20) containing an identical amino acid sequence to recombinant 
MVP vaults but lacking the unchanged Cys-rich peptide tag has a calculated pI of 
5.3.2 The strong interactions between vaults and ANS at low pH could also be 
partially due to electrostatic interactions between the positively charged vaults and 
the negative charged sulfonate group of ANS.20-21  
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In the pH range 4-8, ANS binding occurs in a multi-step manner. In addition 
to the initial binding, the intensity of the fluorescence signal rises at some pint 
during the thermal gradient suggesting increased exposure of buried hydrophobic 
regions. The temperature at which the ANS binds, however, is again strongly pH 
dependent (Fig 2.6), with Tm values of ~ 32.5 ºC at pH 4, 47.5 ºC at pH 5, and 55 ºC 
at pHs 6-8. These results are also supported by the blue shifts observed in the ANS 
emission peak maxima at 485 nm (data not shown). The delayed partial unfolding of 
the vaults at higher pH again suggests a more stable vault conformation at high pH in 
agreement with the circular dichroism and intrinsic fluorescence data. At pH 3, 
however, a continuous decrease in fluorescence intensity is observed with no 
transitions seen throughout the thermal gradient. This again suggests that at pH 3, the 
majority of vault particles are already present as partially unfolded half vaults, in 
which the apolar regions are already more exposed. Continuous decreases in 
fluorescence intensity are presumably due to the intrinsic effect of temperature on the 









































Figure 2.6.Binding of ANS to Vaults as a function of pH and temperature. Vault 
suspensions in the presence of 10x ANS were excited at 385 nm, and the fluorescence 
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2.3.4. Transmission Electron Microscopy  
As an additional tool to confirm the spectroscopic data, EM studies were 
employed as a function of pH and temperature. The rationale for the selection of the 
temperature and pH combinations for the EM images was to cover as many distinct
conformational phases identified in the EPD as possible. As shown in figure 2.7, at 
low pH and temperature (pH 3, 4 ºC) vaults are present in the form of half vault 
monomers, clusters (aggregates) of half vaults, open flower-like structures, and some 
intact vaults that are in the process of coming apart (present as two half vaults in very 
close proximity). The extent of aggregation increases as the temperature is increased 
to 52 ºC and 65 ºC at this pH. At pH 5 and 25 ºC, vaults are primarily intact with 
some minor aggregates and half vaults observed. Increasing temperature to values as 
high as 70 ºC results in highly perturbed and aggregated vault particles. At pH 6 and 4 
ºC, the vaults appear in the native, assembled form. As the temperature increases to 
52 ºC, however, there seems to appear some irregularities in vault structure while still 
primarily maintaining intact forms. The spectroscopic data also suggest a unique 
intermediate (molten globule like, see below) conformational state under this solution 
condition. At pH 8 and 25 ºC, the vaults are intact although considerable aggregation 
is observed as the temperature increases to 75 ºC. In summary, the EM analysis 
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2.3.5. Empirical Phase Diagram (EPD)  
To provide a more global picture of vault behavior under the temperature and 
pH conditions examined, much of the spectroscopic data were integrated into an 
empirical phase diagram (Fig 2.8). We emphasize that empirical phase diagrams 
(EPD) should not be confused with thermodynamic phase diagrams in which 
equilibrium exists between different phases. At least partially irreversibl  aggregation 
as seen here prevents any such analysis. The EPD was constructed from a variety of 
spectroscopic techniques, sensitive to both secondary and tertiary structural changes 
of the vaults. Regions of continuous color define uniform structural states within the 
limit of resolution of the techniques employed. More importantly, abrupt changes in 
color identify alterations in the physical state of the vaults over the conditions 
examined.  
The EPD of the vaults clearly shows a large number of physical states over the 
pH and temperature range studied. The properties of the vaults within each phase can 
be at least partially established by referring to the individual measurements. 
Inspection of the EPD reveals ten distinct phases in the EPD. The blue region labeled 
P1 is the region in which the majority of the complexes are present in the form of half 
vaults. This is confirmed by the enhanced ANS binding as described earlier. The dark 
green phase labeled P2 is also a state containing half vaults with an increased level of 
aggregates as shown in EM studies. The light blue phase (P3) is similar to P1, the 
only difference being a loss of secondary structure as shown by the CD thermal 
unfolding data. The dark blue P4 region is the state of maximum stability based on 
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the predominantly intact vaults. The light green region labeled P5 is also a state of 
high stability with intact vaults as seen in P4 with somewhat decreased secondary 
structure based on CD measurements. The pinkish region designated P6 is similar to 
P5. This pH 5 region, however, is where the earliest transitions in the vault secondary 
structure start. The red region labeled P7, is another transition region like P6 
containing some molten globule-like characteristics based on changes in tertiary
structure preceding those in secondary structure. The green region (P8) is the state of 
minimum stability based upon the magnitude of the spectral changes and the presence 
of aggregated vaults as shown by both EM images and light scattering. The purple 
region (P9) is characterized by the presence of soluble aggregates (oligomers). Th  
red region (P10) is very similar to P9 in terms of tertiary structural content as shown 
by intrinsic and ANS fluorescence data, with the difference between the two a loss of 






























Figure 2.8. Temperature/pH empirical phase diagram of vaults based on intrinsic and 
extrinsic fluorescence, light scattering and CD results. Six distinct phases (P) of the 
vaults were observed; P1, half vaults + aggregates; P2, half vaults + higher level of 
aggregates compared to P1; P3, half vaults (less secondary structural content 
compared to P1); P4, intact stable vault assembly; P5, intact vault assembly (less 
secondary structural content compared to P4);6, similar to P5, even less secondary 
structural content compared to P5; P7, intermediate, molten globule like state; P8, 
highly perturbed, aggregated vaults; P9, intact but highly plumped vault structure; 
P10, aggregates + soluble oligomers of vaults; P11, similar to P10 (less secondary 
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2.4. Discussion 
Employing a variety of techniques, we have extensively characterized the 
behavior of vaults over a wide range of solution variables (i.e. pH and temperature). 
The pH range examined covers the extent of physiological pH in different cellular 
compartments and organs and should therefore provide a basis for further 
interpretation of vault behavior in vivo. In addition, the combination of pH and 
temperature effects on the structural integrity of vaults should aid in formulation of 
these nanocapsules for drug delivery since one mechanism by which therapeutic 
agents entrapped in vaults could be released is an opening of the intact vault structure. 
  The overall secondary structure of vaults was shown to be highly pH 
dependent since CD showed changes in the secondary structural content of vaults 
from a mixture of α-helical and β-sheet at low pH to predominantly β-sheet at 
intermediate pH to increased α-helix at high pH. Thermal unfolding CD studies over 
the pH range of 3-8 showed disruption and loss of secondary structure at higher 
temperatures. Transitions were shifted to higher temperatures at increasi g pH 
suggesting a more stable, intact vault complex at neutral pH.  
The induced stability of vault tertiary structure as a function of increasing pH 
was supported by ANS binding experiments. The onset of ANS binding to previously 
buried apolar regions was shifted to higher temperatures by increasing pH again 
suggesting more stable vault assembly at neutral compared to low pH, in agreement 
with the CD thermal unfolding data. 
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Intrinsic fluorescence studies demonstrate a 1-5 nm red shift in tryptophan 
emission maxima as a function of temperature across the pH range, suggesting only 
limited unfolding of the vault complex. The transition temperatures observed exactly 
match those obtained from the ANS studies, supporting the presence of a thermally 
induced event that at least partially opens up the vault’s intact structure. Larg r red 
shifts, however, were observed at high pH compared to low, presumably due to the 
presence of intact vaults at neutral pH as oppose to partially unfolded, half vaults 
under acidic conditions.  
Zon et al. demonstrated that MVP molecules interact with each other via a 
coiled coil domain in their C-terminal halves forming MVP-MVP subunits that are 
the basis for vault assembly.6 Formation of vault like particles by expression of only 
MVP in insect cells in the absence of other minor vault proteins and RNA further 
suggests the dominant role of MVP in the assembly of vaults. The secondary and 
tertiary structural changes seen here could severely alter the integrity of vault 
assembly by disrupting MVP-MVP interactions. With the goal of developing vaults 
into drug delivery vehicles, however, some of the observed alterations leading to 
opening of intact vault structure are advantageous for release of therapeutic g nts 
from vault’s cavity.  
Physical degradation pathways, particularly aggregation, could severely 
jeopardize the vault’s integrity and disrupt their utility as a delivery device. Th  
tendency of vaults to aggregate was studied by multiple techniques including static 
light scattering and OD350 measurements. The pH dependent aggregation behavior of 
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vaults observed from static light scattering finds the onset of aggregation shifted to 
higher temperatures as the pH is increased from 5 to 8, suggesting more stable vaults 
near neutral pH. A unique phase, labeled P7 in the EPD, is distinguishable at pH 6. 
The spectroscopic data suggest the presence of an intermediate, molten globule-like 
state in this region based on the finding that tertiary structure changes prec de 
secondary structure alterations at this pH. This is seen to a lesser extent at pH 5 (P6). 
Molten globule states are characterized by the presence of extensive secondary 
structure, minimal tertiary interactions (extensive solvent exposure of prviously 
buried apolar moieties), and a tendency to aggregate.22 As described above, the 
current results suggest such a state for vaults under these limited solution conditions 
based on the CD results (Fig 2.2, pH 6),  exposure of the previously buried indole 
side chains (Fig 2.4a and Fig 2.6), and the tendency of vaults to aggregate (Fig 2.5) in 
these regions (P6 and P7). Referring to the EM images obtained at pH 6 and 52 ºC, 
the vaults appear to be less plump and a bit disordered and irregular in this region 
which may also represent these states. Further, dynamic light scattering (DLS) shows 
a significant increase in hydrodynamic diameter of vault particles at pH6 starting at ~ 
55 ºC (data not shown). Nevertheless, deconvolution of the DLS data in this region 
provides evidence for the presence of extensive quantities (over 90%) of monomeric 
particles further supporting the presence of less expanded vault structure (in 
agreement with EM analysis). The less expanded structure of vaults under these 
conditions may also reflect an increase in the particle’s density resulting in i creased 
scattering (scattering intensity is proportional to (dn/dc)2 ).    
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2.5. Conclusion 
Understanding the effects of pH and temperature on vault stability should aid 
in the ultimate goal of utilizing these particles as potential drug delivery devices. Our 
studies show that vault conformation was altered as a function of decreasing pH in 
which intact particles at neutral pH open into flower-like structures at acidic pH. 
Opening of intact vaults could be potentially developed as an intracellular controlled-
release device for drug delivery.  
With the identification of at least ten distinct apparent phases in the empirical 
phase diagram of vaults, it is clear that they can assume a wide variety of different 
structural forms, consistent with a highly dynamic nature. Comparison of the effects 
of temperature and pH show that vaults are significantly more stable at high pH and 
below 40 ºC as encompassed by the blue P4 phase in the EPD. The most unstable, 
conformationally perturbed structures are present at pH 4 and 5 above 60 ºC 
identified by the green P8 region in the EPD.  
In vivo, naturally occurring vault nanocapsules posseses a dynamic structure 
and appear to be highly interactive with their surrounding environment.15 
Construction of an EPD based on techniques such as hydrogen/deuterium exchange, 
red edge shift spectroscopy, time correlated single photon anisotropy measurements, 
pressure perturbation calorimetry, and high resolution ultrasonic spectroscopy that are 
more sensitive to the dynamic of vault structure should help to clarify this aspect of 
vault behavior. 
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3.1. Introduction 
Malignant tumors of the central nervous system are the third leading cause of 
cancer-related deaths in adolescents and adults between the ages of 15 and 341. 
Glioblastoma multiforme (GBM) is the deadliest form of malignant brain tumor with 
~ 13,000 annual deaths in the United States alone2. Available therapies (i.e., surgery, 
radiation and chemotherapy) result in ~ 20% survival rates with an average of two 
and a median of about one year survival periods3. This has resulted in extensive 
efforts toward the development of novel treatments for malignant brain tumors, one 
of which involves the use of anti-brain tumor cytotoxins with high specificity towards 
cancer cells3. 
It has been previously reported that fusion of Interleukin-13 with a bacterial 
toxin, Pseudomonas Exotoxin A (PE) generates a proteinaceous complex with very 
high specificity towards brain tumor cells4. The IL-13 cytokine, containing a high 
degree of structural homology to IL-4, performs a variety of immunomodulatory 
functions with both pro- and anti-inflammatory immune actions5,6. On untransformed 
tissue cells, IL-13 and IL-4 compete for binding to IL13/4R, a heterodimeric receptor 
complex composed of IL13Rα1 and IL4Rα. In contrast, IL13Rα2 which is a highly 
specific binding target of IL-13 alone is exclusively present on the surface o  cancer 
cells7. The novel fusion cytotoxin of this study contains a genetically engineered form 
of IL-13 in which the glutamic acid residue at position 13 has been replaced by a 
lysine residue (IL13.E13K). Position 13 has been recognized as a critical hot spot in
the IL-13 wild type sequence involved in binding to IL13/4R. The mutated version, 
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however, neither binds nor activates IL13/4R, but retains specificity towards glioma-
restricted IL13Rα27. The bacterial toxin portion of the fusion protein, PE4E, is a 
derivative of Pseudomonas Exotoxin A. It is composed of three major domains; 
domain I binds to the cell surface receptor (i.e., α2-macroglobulin), domain II 
catalyzes the translocation of the toxin out of endosomes into the cytosol, while 
domain III contains the ADP-ribosylation activity which inactivates elongation factor 
2 resulting in cell death8,9. The glutamic acid residues of PE4E at positions 57, 246, 
247, and 249 have been substituted with basic amino acids to inhibit binding to its 
cell surface receptor on normal cells10,11. Therefore, fusion of Pseudomonas Exotoxin 
A with IL-13 essentially generates a cytotoxic entity targeted specifically towards 
cancer cells. 
To develop this novel fusion cytotoxin as a safe and efficacious therapeutic, a 
robust formulation (liquid or lyophilized) that retains the protein’s stability and 
activity over its entire shelf life is required. Proteins are, however, frequently 
thermolabile and susceptible to a variety of physical and chemical degradations, ofte  
leading to their altered immunogenicity and loss of biological activity. Thiscan 
introduce significant challenges to the development of safe, efficacious, and stable 
protein formulations12.  
Given this high degree of structural complexity and associated degradation 
pathways, the FDA requires that the stability and activity of potential protein 
therapeutics be demonstrated in real time under the proposed labeled storage 
conditions. These types of studies, however, demand significant resources be 
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dedicated to them for extended periods of time since the common shelf life of protein 
drugs are usually at least 18-24 months13. One time and cost effective approach is to 
conduct accelerated stability studies to screen for potential formulations wth 
properties that lead to enhanced stability under more moderate storage conditions. 
Such accelerated studies typically involve stressed conditions (e.g., elevated 
temperatures, suboptimal pH, high or low ionic strengths) to facilitate protein 
degradation in a short period of time.         
Herein, we have employed a variety of spectroscopic techniques (i.e., circular 
dichroism, intrinsic and extrinsic fluorescence, and static light scattering) to 
characterize the thermal stability of the fusion protein in solution under accelerated 
degradation conditions. The results from these analyses served as a basis to develop a 
high throughput screening assay to identify potential GRAS (Generally Regarded s 
Safe) stabilizers that inhibited aggregation and enhanced conformational stability of 
the fusion protein. We also show that the protein’s thermal stability can be understood 
in terms of the behavior of its individual domains.  
 
3.2. Materials & Methods 
3.2.1. Materials 
Highly purified bulk protein samples are stored frozen in 25 mM succinate 
buffer (200 mM urea, 150 mM NaCl, pH 4.8). The purity of the bulk samples was 
confirmed by RP-HPLC studies in which a homogeneity of >99.4% was established. 
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All other chemicals were of analytical grade and were purchased from Sig a (St. 
Louis, MO) and Fisher Scientific (Pittsburgh, PA).  
 
3.2.2. Sample Preparation.                                                                                         
Frozen protein solution was thawed at room temperature and was buffer 
exchanged into 20 mM isotonic citrate phosphate buffer ranging from pH 3 to 8, at 
one pH unit intervals (the isotonicity was maintained using sodium chloride). For 
buffer exchange, protein samples were dialyzed at refrigerator temperatures using 
Spectra/Por molecular porous membrane tubing (SpectrumLab, Rancho Dominguez, 
CA) with a 15KDa MW cutoff. Samples were examined at a concentration of 0.1 
mg/ml for all studies with the exception of CD and excipient screening studies in 
which samples at 0.2 and 0.35 mg/ml were used, respectively. The concentration of 
protein samples after dialysis was determined by UV absorption spectroscopy (A280nm) 
using E1cm 0.1% of 1.2. The fusion protein’s extinction coefficient was calculated 
using the program Protparam on the Expasy server 
(http://www.expasy.ch/tools/protparam.html). For all studies, three independent 
samples were evaluated to ensure reproducibility of the measurements. Values are 
presented as averages with accompanying standard deviations.  
3.2.3. Far-UV Circular Dichroism (CD) Spectroscopy 
CD spectra were acquired using a Jasco J-810 spectropolarimeter equipped 
with a 6-position sample holder and a Peltier temperature controller. The CD spectra 
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were obtained from 260-190 nm with a scanning speed of 20 nm/min, a 2 sec 
response time and an accumulation of 3. To study thermal transitions (melting curves) 
of the fusion protein, the CD signals at 222 nm were monitored in 0.1 cm pathlength 
cuvettes every 0.5 °C over a 10 to 85 °C temperature range employing a temperature 
ramp of 15 °C/hr.  
3.2.4. Intrinsic Tryptophan (Trp) Fluorescence Spectroscopy 
 Fluorescence spectra were acquired using a Photon Technology International 
(PTI) spectrofluorometer (Lawrenceville, NJ) equipped with a turreted 4-position 
Peltier-controlled cell holder. An excitation wavelength of 295 nm was used to 
primarily excite Trp residues and the emission spectra were collected from 310 to 400 
nm with a step size of 1 nm and a 1 sec integration time. Excitation and emission slits 
were set at 3 and 1 nm, respectively. Light scattering was also monitored at 295 nm
using a separate photomultiplier placed at 180º to the fluorescence detector. Both the 
fluorescence intensity and the light scattering data were normalized wth respect to 
the initial reading at 10 °C. Emission spectra were collected every 2.5 °C with a 3 
min equilibration time over a temperature range of 10 to 85 °C. A buffer baseline was 
subtracted from each raw emission spectrum.  
Peak positions of the emission spectra were obtained from polynomial fits 
using Origin software using a “center of spectral mass” method.  Due to the natur of 
center of spectral mass analysis, the reported emission peak position values do not 
correspond to the actual peak positions, but do accurately reflect the changes and 
produce more reproducible results than alternative methods. The actual peak positions 
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determined by derivative analysis of the native protein are shifted approximately 10-
14 nm from their center of mass values. 
 
3.2.5. ANS Fluorescence Spectroscopy  
Accessibility of apolar sites on the fusion protein was monitored by 
fluorescence emission of the extrinsic probe 8-Anilino-1-naphthalene sulfonate 
(ANS). Each sample contained a 20-fold molar excess of ANS to protein, an optimal 
ratio determined in preliminary experiments. The ANS was excited at 385 nm and 
emission spectra were collected from 425-550 nm with a step size of 1 nm and 1 sec 
integration time. Emission spectra were collected every 2.5 °C with 3 min of 
equilibration over a temperature range of 10 to 85 °C using a Photon Technology 
International (PTI) spectrofluorometer (Lawrenceville, NJ) equipped with a turreted 
4-position Peltier-controlled cell holder. Slits were set at 5 nm excitation and 
emission in the pH range of 5-8, 3 nm excitation/2 nm emission at pH 3, and 4 nm 
excitation and emission at pH 4; data were normalized with respect to the initial 
reading at 10 °C to permit direct comparison. The ANS-buffer baseline with almost 
no fluorescence at each corresponding pH was subtracted from raw emission spectra.  
 
3.2.6. Empirical Phase Diagram (EPD) 
To facilitate analysis of the complex data sets, an empirical phase diagram 
was constructed employing CD signals at 222 nm, intrinsic Trp fluorescence peak 
position, static light scattering, and ANS fluorescence intensity data. All calculations 
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were performed using Matlab software (The MathWorks, Natick, MA). In brief, the 
normalized experimental data at each coordinate (i.e., at specific temperature and pH 
combinations) are first converted into an N-dimensional vector, where N refers to the 
number of variables included (i.e., number of different types of data). The complete 
data sets from all measurements are now defined as multi-dimensional vectors in a 
temperature/pH phase space. Projectors of each individual vectors are then calculated 
and summed into an N × N density matrix. By definition, an N × N matrix has N sets 
of eigenvalues and eigenvectors. The individual vectors at each coordinate are 
truncated into 3-dimensional vectors and re-expanded into a new basis set consisting 
of the three eigenvectors corresponding to the three largest eigenvalues. The resultant 
3-dimensional vectors are then converted into a color plot with each vector 
component corresponding to a color using an arbitrary RGB (red, green, blue) color 
system. Details of the mathematical theory and calculation process can be found 
elsewhere14.  
 
3.2.7. High Throughput Excipient Screening  
Protein samples (0.35 mg/ml) in 20 mM isotonic citrate phosphate buffer, pH 
5.0 were incubated in the presence and absence of excipients at 45 °C for 4 hrs and 
aggregation kinetics were monitored by measuring the optical density (O.D.350nm) 
every 2 min using a SpectraMax-M5 96 well microplate reader equipped with a 
temperature controller (Molecular Devices, Sunnyvale CA). A buffer baseline 
containing only excipient in buffer was subtracted from data obtained from the 
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excipient solution in the presence of protein. The optimal protein concentration of 
0.35 mg/ml was chosen from initial concentration dependent aggregation studies 
(data not shown). Concentrated stock solutions of excipients were prepared by 
dissolution of excipients in 20 mM isotonic citrate phosphate buffer, pH 5. Upon 
dissolution, the pH was adjusted to 5 by addition of HCl or NaOH. 
The percent inhibition of aggregation (%IA) was calculated using: 
 
%IA = 100- [OD 350(E) / OD 350(NE)] x 100 
 
in which OD 350(E) and OD 350(NE) are the changes in the optical density of protein in 




3.3.1. Far-UV Circular Dichroism (CD) Spectroscopy  
Alterations of the fusion protein secondary structure were studied by 
monitoring the changes in the CD signal over a wide range of pH (3 to 8) when 
subjected to thermal gradients from 10 to 90 ºC. The CD spectra at 10 °C exhibit 
distinct pH dependency (Fig 3.1a). At pH 3 and 4, a broad minimum is observed in 
the region of 208-225 nm with a shoulder at 208 nm, indicative of a mixture of α-
helical and β-sheet structures. Two distinct minima at 208 and 222 nm observed in 
the pH range of 5-8 suggest the presence of predominantly α-helical structure. The 
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spectrum at pH 5 is much less intense compared to other pH values suggesting some 
form of unique structure under this pH condition. Poor quality data below 200 nm 
prevented deconvolution of spectra for quantitative estimation of secondary structural 
content.  
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Figure 3.1.a) CD spectra of fusion protein at various pH values. CD spectra were 
recorded at 10 ° C from 190 to 260 nm at each of the indicated pH values (n =3).
Error bars are not shown to enhance clarity. b) The effect of temperature on the 
secondary structure at different pH values. Molar ellipticity at 222 nm was monitored 
as a function of temperature over the pH range 3–8 (n = 3).  
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The effect of temperature on protein secondary structure was further 
investigated employing thermal melt analysis by monitoring the CD signals at 222 nm 
(Fig 3.1b). An overall loss in the secondary structure is observed as a function of 
increasing temperature across the pH range examined. Sharp transitions are b erv d 
in the pH range of 4-6 with an approximate onset transition temperatures of ~ 25 °C 
at pH 4, ~ 42.5 °C at pH 5, 6, 7,  and ~ 52.5 °C at pH 8. The transitions at extreme pH 
values, however, are more subtle presumably suggesting either the presence of 
already altered and partially unfolded conformational states at pH 3 (seebelow) or 
more stable secondary structure at pH 7 and 8 over the temperature range examined.  
The dramatic decrease in the transition temperatures by ~ 25 °C going from 
pH 8 to 4, suggests reduced stability of the fusion protein secondary structure at 
acidic pH values. In the pH range of 5-7, similar onset transition temperatures are 
observed, although, the extent to which the secondary structure is altered is somewhat 
different; less extensive perturbations are observed at higher pH values suggeting 
more stable secondary structure at neutral and basic pH values. 
 
3.3.2. Intrinsic Trp Fluorescence Spectroscopy 
Alterations in fusion protein tertiary structure were studied by monitoring the 
changes in its Trp emission peak position and fluorescence intensity as a function of 
pH and temperature. An overall red shift in the Trp emission maxima is observed as a 
function of increasing temperature over the pH range examined (Fig 3.2a) suggestin  
enhanced exposure of the indole side chains to solvent upon conformational 
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alterations15. The examined fusion protein contains a total of 12 tryptophan residues, 
out of which 11 belongs to the toxin domain suggesting its dominant role in the 
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Figure 3.2.a) Tryptophan emission peak position as a function of pH and temperature. 
Protein solutions at pH 3–8 were heated from 10 to 85 °C, and the fluorescence 
emission maxima were monitored (n=3) upon excitation at 295 nm. b) Tryptophan 
emission fluorescence intensity as a function of pH and temperature. Protein solution  
at pH 3–8 were heated from 10 to 85 °C, and the fluorescence intensity was 
monitored (n=3).  
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The midpoints of the thermal transitions occur at ~ 36 °C at pH 4, ~ 46 °C at 
pH 5, ~ 50 °C at pH 6, and ~ 48 °C at 7 and 8 suggesting that protein at neutral pH 
values is the most stable. No clear transitions were observed at pH 3 (The transition 
temperatures were determined by fitting the data to a non-linear sigmoidal function 
defined by the Boltzman equation). The extent of exposure of indole side chains to 
solvent on average is somewhat similar across the pH range with red shifts of ~ 3-4.5
nm in magnitude. The small red shifts in peak position indicate partial unfolding of 
the protein with increasing temperature (Fig 3.2a). The initial peak positions near 330 
nm (calculated based on a direct peak picking method) suggest that on average, the 
indole side chains of the 12 Trp residues in the fusion protein are buried in a more 
apolar environment. The temperature-dependent Trp fluorescence intensity data 
exhibited weak but distinct transitions across the pH range of 3-8 over a similar range 
seen in the peak shift studies (Fig 3.2b). The sharp decrease in fluorescence intensity 
at pH values 4 and 5 is presumably due to precipitation of protein at these pH values 
at higher temperatures (see below).  
 
3.3.2.1. Static Light Scattering 
The aggregation behavior of the fusion protein was simultaneously examined 






















Figure 3.3.Static light scattering of fusion protein as a function of pH and temperature. 
Protein solutions at pH 3–8 were heated from 10 to 85 °C, and the scattering intensity 
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The onsets of aggregation are highly pH dependent and occur at ~ 30 °C at pH 
4, ~40 °C at pH 5, and ~45 °C at pH 6, 7, and 8 (Fig 3.3). Overall, the onset of 
aggregation is shifted to lower temperatures with decreasing pH suggestin a less 
stable protein at more acidic pH values in good agreement with both the CD and 
intrinsic fluorescence data. The extent to which the fusion protein aggregates is lso 
highly pH dependent with the greatest extent of aggregation observed at pH 4 and 5; a 
decrease in light scattering after the initial increase at higher temperatures is 
presumably due to precipitation of insoluble aggregates in agreement with the 
intrinsic fluorescence intensity data. This phenomenon is not observed in the pH 
range of 6-8. A slight increase in light scattering signal at pH 7 and 8 is due to 
formation of soluble oligomers. No clear transitions were observed at extreme pH 3, 
presumably due to the presence of already altered and partially unfolded protein as 
already suggested by the CD and Trp fluorescence results.  
 
3.3.3. ANS Fluorescence Spectroscopy 
 Alterations in the tertiary structure of the fusion protein were further studied 
in the presence of an extrinsic fluorescence probe, 8-Anilino-1-naphthalene sulfonate 
(ANS). The fluorescence of ANS is highly quenched in aqueous solutions but 
increases dramatically in non-polar environments16,17(Fig 3.4a). In addition, the 
emission maximum of the probe is usually blue-shifted upon binding to apolar 
regions of proteins (Fig 3.4b). Although the negative charge on ANS can occasionally 
cause it to bind to positively charged sites on proteins, it is generally accepted as a 
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probe of apolar sites. The accessibility of the ANS probe to hydrophobic regions of 











































Figure 3.4.a) Binding of ANS to fusion protein as a function of pH and temperature. 
Protein solutions in the presence of a 20 molar excess of ANS were excit d at 385 nm, 
and the fluorescence intensity at 485 nm was monitored as a function of temperature 
at each indicated pH (n=3). b) ANS emission peak position as a function of pH and 
temperature (calculated using the “center of spectral mass” method). Protein solutions 
at pH 3–8 were heated from 10 to 85 °C, and the fluorescence emission maxima were 
monitored (n=3) upon excitation at 385 nm.  
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The temperature at which the ANS binds to the protein is highly pH 
dependent with an approximate onset of thermal transitions at ~ 25 °C at pH 4, ~ 
40 °C in the pH range 5-7, and ~ 35 °C at pH 8 (Fig 3.4a). The earlier unfolding of 
the fusion protein at pH 4 compared to other pH values suggests a less stable protein 
conformation at this pH in agreement with both the circular dichroism and light 
scattering data. At pH 3, however, a continuous decrease in fluorescence intensity is 
observed with no transitions apparent throughout the thermal gradient. This suggests 
that at pH 3, the protein is substantially unfolded (note that data at each pH has been 
normalized with respect to the initial value at 10 °C). The enhanced binding of ANS 
to apolar regions of the fusion protein above pH 3 as a function of increasing 
temperature is supported by the blue shifts of the ANS emission peak maxima at ~ 
485 nm (Fig 3.4b). This is not observed at pH 3 where ANS is already bound to the 
partially unfolded protein at the initial temperature of 10 °C. The early blue shifts
observed at pH 4 confirm the presence of less stable and altered forms of protein at 
this pH as suggested by the intensity data.   
 
3.3.4. Empirical Phase Diagram (EPD) 
The spectroscopic data were integrated into an empirical phase diagram to 
provide a more global picture of the fusion protein behavior under the temperature 
and pH conditions examined (Fig 3.5). We emphasize that empirical phase diagrams 
should not be confused with thermodynamic phase diagrams in which equilibrium 
exists between different phases. At least partially irreversible aggregation as seen here 
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prevents any such analysis. Regions of continuous color define uniform structural 
states while abrupt changes in color identify alterations in the physical state of the 
protein over the conditions examined. The properties of the fusion protein within each 
phase can be established by referring to the individual measurements.  
The EPD of the fusion protein clearly shows a number of distinct 
conformational states over the pH and temperature range examined. The green re ion 
labeled as P1 is the region of maximum stability with protein present in what can be 
defined as its native-like and folded conformation. The purple region labeled P2 is a 
state of perturbed tertiary structure and contains soluble oligomers and aggregates of 
the fusion protein. The region labeled P3 is the state of minimum stability with 
extensive aggregation and perturbed secondary and tertiary structures.  The orange 
region P4 is very similar to P1, the only difference being a loss of secondary structure 
as shown by the CD spectra and thermal unfolding data. The P5 green region contains 
extensively unfolded structure. The dark green P6 region is similar to P5, with an 
even greater extent of unfolding seen in the P6 region as implied in the tryptophan 















Figure 3.5.Temperature/pH empirical phase diagram of the fusion protein based on 
intrinsic and extrinsic fluorescence, light scattering and CD thermal melt data. For a 
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3.3.5. High Throughput Screening for Inhibitors of Protein Aggregation  
The pH and temperature conditions under which the fusion protein showed 
marginal stability were identified by analysis of the raw data and identification of 
apparent phase boundaries (i.e. abrupt changes in color) in the empirical phase 
diagram. One such boundary was identified at pH 5 and ~ 45 °C based on extensive 
aggregation of protein (Fig 3.3 and 3.5). Therefore, aggregation kinetics under this 
condition was selected as a tool to screen for potential stabilizers. A high throughput 
screening assay was developed (as described in the method section) to examine the 
ability of a library of Generally Regarded as Safe (GRAS) excipients to inhibit 
aggregation of the fusion protein.  Figure 6 shows representative aggregation kinetic 
traces of protein in the presence of selected excipients. The left panel includes 
excipients that inhibited the aggregation of protein whereas the ones in the right panel 
































Figure 3.6.Aggregation kinetic traces of the fusion protein in the presence of sel cted 
excipients. Protein samples (0.35 mg/ml) in 20 mM isotonic citrate phosphate buffer, 
pH 5.0 were incubated in the presence and absence of excipients at 45 °C for 4 hr and 
aggregation kinetics were monitored by measuring the optical density (OD350nm) 
every 2 min.  


















 Protein + Arginine 0.3M
 Protein + Dietanolamine 0.3M
 Protein + Gn-HCl 0.3M


















 Protein + Dex Sulfate 0.0075 mM
 Protein + Sodium Citrate 0.2 M
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A complete list of excipients examined and their inhibitory effect on protein 
aggregation represented by percent inhibition of aggregation (%IA) is shown in 
























Excipient (conc.) %IA Excipient (conc.) %IA 
 Dextran Sulfate (0.0075mM) 81                     Dietanolamine (0.3M) 4 
   Dextran Sulfate (0.003mM) 78                    Guanidine-HCl (0.3M) 4 
            Sodium Citrate (0.2M) 64                        Tween 80 (0.05% w/v) 4 
     Dextran Sulfate (0.02mM) 63                       Lactic acid (0.15M) 3 
               Dextrose (20% w/v) 61                  Bridge 35 (0.01% w/v) 3 
 Dextran Sulfate (0.0003mM) 53                        Sucrose (10% w/v) 3 
                 Sorbitol (20% w/v) 48                      Trehalose (10% w/v) 3 
              Trehalose (20% w/v) 42                  Bridge 35 (0.05% w/v) 0 
           Glutamic acid (0.15M) 40                              Arginine (0.3M) -3 
                 Lactose (10% w/v) 37             2-OH propyl ğ-CD (10% w/v) -5 
                 Sucrose (20% w/v) 34                            Gelatin (5% w/v) -6 
            Sodium Citrate (0.1M) 33                              Glycerol (10% w/v) -6 
             Tween 80 (0.1% w/v) 33                              Histidine (0.3M) -8 
             Tween 20 (0.1% w/v) 28                     Phytic Acid (5:1 w/w)* -13 
             Bridge 35 (0.1% w/v) 24               Calcium Chloride (0.015M) -14 
               Mannitol (10% w/v) 23                      Phytic Acid (1:1 w/w)* -15 
                 Sorbitol (10% w/v) 22             2-OH propyl γ-CD (5% w/v) -16 
           Tween 20 (0.05% w/v) 22                 α-Cyclodextrin (2.5% w/v) -19 
                Glycerol (20% w/v) 18  Arginine/Glutamic Acid (25mM each) -21 
               Dextrose (10% w/v) 17               2-OH propyl β-CD (5% w/v) -22 
          Tween 80 (0.01% w/v) 15                  Phytic Acid (10:1 w/w)* -23 
                      Glycine (0.3M) 12            2-OH propyl β-CD (10% w/v) -26 
                       Proline (0.3M) 11  Arginine/Glutamic Acid (50mM each) -27 
          Tween 20 (0.01% w/v) 9                   Pluronic F-68 (0.05% w/v) -29 
          Aspartic Acid (0.075M) 9                 Pluronic F-68 (0.1% w/v) -29 
    Pluronic F-68 (0.01% w/v) 7 Albumin from Human Serum (5% w/v) -48 
                Malic Acid (0.15M) 4     
 
        Table 3.1.Percent inhibition of the fusion protein aggregation (%IA) in the    
         presence of variety of excipients after 240 min. The average standard deviation   
         is ± 5% (n=3).   
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A number of excipients manifested the ability to significantly inhibit the 
aggregation of the fusion protein (Table 3.1). Selected concentrations of polyanions 
(dextran sulfate), polysaccharides (sucrose, dextrose, lactose, and trehalose), polyols 
(sorbitol and glycerol), salt (sodium citrate), and detergents (Tween 20 and 80) were 
among the most effective stabilizers as shown by their inhibition of the protein 
aggregation by ~ 25 to 80%. The negative %IA values are indicative of induced 
aggregation of protein in the presence of the indicated excipients. 
 
3.3.6. Optimization of Excipient Combinations and Concentrations  
Based on the results obtained from preliminary aggregation kinetic-based 
screening studies, combinations of some of the more promising stabilizers wer 
chosen to see if there was an additive or synergistic effect of these compounds on the 
inhibition of protein aggregation. A complete list of all combinations examined is 
presented in Table 3.2. The combination of sodium citrate (≥ 0.1M) with sugars or 















Excipient (conc.) % IA Excipient (conc.) % IA 
   Sodium citrate 0.1 M + 20% Dextrose 97   Sodium citrate 0.15 M + 5% Trehalose 81 
     Sodium citrate 0.3M + 20% Sorbitol 96 Sodium citrate 0.05 M + 20% Trehalose 81 
   Sodium citrate 0.15M + 20% Sorbitol 96  Sodium citrate 0.15 M + 10% Dextrose 80 
    Sodium citrate 0.3M + 20% Dextrose 95       Sodium citrate 0.3M + 10% Lactose 77 
    Sodium citrate 0.1 M + 20% Sorbitol 94                Tween 80 + 20% Dextrose 77 
   Sodium citrate 0.15M + 20%Dextrose 92    Sodium citrate 0.05 M + 10% Sorbitol 66 
 Sodium citrate 0.05 M + 20% Dextrose 92 Sodium citrate 0.05 M + 10% Trehalose 65 
  Sodium citrate 0.1 M + 20% Trehalose 90  Sodium citrate 0.05 M + 10% Dextrose 62 
     Sodium citrate 0.1 M + 10% Sorbitol 90               Tween 80 + 20% Trehalose 61 
  Sodium citrate 0.1 M + 10% Trehalose 89    Sodium citrate 0.1 M + 10% Dextrose 61 
   Sodium citrate 0.3M + 20% Trehalose 88     Sodium citrate 0.15M + 10% Lactose 57 
   Sodium citrate 0.05 M + 20% Sorbitol 87                  Tween 80 + 20% Sorbitol 49 
   Sodium citrate 0.15 M + 10% Sorbitol 85     Sodium citrate 0.15 M + 5% Dextrose 45 
  Sodium citrate 0.15M + 20%Trehalose 84         Sodium citrate 0.1 M + 5% Lactose 40 
     Sodium citrate 0.15 M + 5% Sorbitol 84                   Tween 80 + 10% Lactose 19 
Sodium citrate 0.15 M + 10% Trehalose 83     
 
Table 3.2.Percent inhibition of the fusion protein aggregation (%IA) in the presence 
of combination of variety of excipients after 240 min. The average standard deviation 
is ± 5% (n=3).   
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3.3.7. Effect of Selected Excipients on the Conformational Stability of Fusion Protein 
 To further explore if the inhibitors of aggregation were also stabilizing the 
structure of the protein, the conformational stability of the fusion protein was 
examined in the presence of the aforementioned combinations. Effects of 
combinations of sodium citrate with sugars (trehalose and dextrose) and a polyol 
(sorbitol) on the tertiary structure of the fusion protein were examined employing 
tryptophan fluorescence spectroscopy. Enhanced exposure of indole side chains to 
solvent upon conformational alterations (i.e. unfolding) is manifested by shifts in Trp
emission maxima to higher wavelengths (see Fig 3.2a). The stabilizing agets should 
therefore delay or inhibit such temperature dependent peak shifts.  
These studies were performed at protein concentration of 0.1 mg/ml in 
histidine buffer, pH 6.5. All of the preliminary screening studies, however, were 
performed at the suboptimal pH 5 at which the degradation of protein was accelerated. 
The choice of pH 6.5 for the final stage of excipient screening was based on the 
desire to examine the stability of the fusion protein in the presence of stabilizers at a 
pH condition close to the targeted formulation pH. Combinations of sodium citrate 
with dextrose, trehalose, or sorbitol all delayed the unfolding of protein by shifting 
the Tm values to higher temperatures by ~ 3 to 6 °C. Table 3.3 summarizes all of the 








Exipient (conc.) Tm (°C) ∆Tm (°C) 
                                       Fusion protein 47.3   
   0.1M sodium citrate + 20% Dextrose 53.8 6.5 
   0.05M sodium citrate + 20% Sorbitol 53.6 6.3 
     0.1M sodium citrate + 20% Sorbitol 53.5 6.2 
  0.1M sodium citrate + 20% Trehalose 53.4 6.0 
 0.05M sodium citrate + 20% Dextrose 53.2 5.9 
0.05M sodium citrate + 20% Trehalose 53.1 5.7 
  0.1M sodium citrate + 15% Trehalose 52.8 5.5 
   0.1M sodium citrate + 15% Dextrose 52.5 5.2 
     0.1M sodium citrate + 15% Sorbitol 52.3 5.0 
   0.05M sodium citrate + 10% Sorbitol 52.1 4.7 
0.05M sodium citrate + 10% Trehalose 52.0 4.7 
  0.1M sodium citrate + 10% Trehalose 51.7 4.3 
   0.1M sodium citrate + 10% Dextrose 51.5 4.2 
    0.1M sodium citrate + 10% Sorbitol 50.7 3.4 
 0.05M sodium citrate + 10% Dextrose 50.3 3.0 
 
                       Table 3.3.Midpoint of protein thermal transitions in the presence of  
                       combination of selected excipients. The average standard deviation is   
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3.4. Discussion 
The novel fusion anti-brain tumor cytotoxin of this study is composed of 
mutated versions of Pseudomonas Exotoxin A and Interleukin-13 in which the 
mutations collectively result in inhibition of the cytotoxin binding to untransformed 
cells, further enhancing its specificity towards glioma cells. Here, we have 
characterized the thermal stability of the fusion protein over a wide range of pH (3-8) 
and temperature (10-85 °C) employing a variety of spectroscopic techniques in search 
of a stable liquid formulation to permit the protein’s therapeutic use.  
The CD spectra at 10 °C exhibit predominantly α-helical structure over the pH 
range of 5-8 (Fig 3.1a), in agreement with the highly rich α-helical contents of both 
domains. IL-13 is known to be folded into four α-helical bundles18. The Pseudomonas 
Exotoxin A is also rich in α-helical content, specifically in its domain II which 
contains six α-helices9. The CD spectra of both the wild-type toxin and cytokine 
exhibit minima at 208 and 222 nm very similar to the results obtained herein for the 
fusion protein19,20.  
Mere et. al. have shown that an acid-triggered unfolding event is an essential 
step in the retrograde cycling of the exotoxin to escape from endosomal 
compartments21. Tryptophan 305 was identified as a key membrane anchor to initiate 
the translocation of the exotoxin out of the endosome. This residue is, however, 
buried in the hydrophobic core of PE at neutral pH, masked by helix F of domain II 
(i.e., the translocation domain). Upon acidification in the low pH environment of the 
endosome, helix F rearranges to expose the tryptophan residue to the surrounding 
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environment allowing it to insert its side chain into endosomal membranes. Our 
studies also show that the fusion protein α-helical content is highly pH dependent 
with reduced amounts of α-helix as the pH is lowered (Fig 3.1a). This is consistent 
with a similar acid triggered α-helical disruptive mechanism as seen in the native 
toxin. 
The effect of temperature on secondary structure was further investigated by 
monitoring the CD signals at 222 nm. Previous studies with PE show such transitions 
occurring at ~ 45-50 °C at pH 7.422. The fusion protein’s transitions occur in the same 
temperature range at ~ 45 and 57 °C at pH 7 and 8 respectively (Fig 3.1b) suggesting 
that the overall secondary structural stability of the protein may be significantly 
influenced by its toxin domain with minimal contributions from IL-13. This is 
consistent with the size of the two domains in which the toxin domain constitutes ~ 
84% of the total fusion protein’s mass. 
Alterations in the fusion protein tertiary structure were studied employing 
intrinsic tryptophan and extrinsic ANS fluorescence. An overall red shift of the Trp 
emission maximum was observed as a function of increasing temperature over the pH 
range examined (Fig 3.2a). The midpoint of the thermal transitions was highly pH 
dependent and in general increased as a function of increasing pH occurring at ~ 
36 °C at pH 4 and ~ 48 °C in the neutral pH range of 7-8. Pseudomonas Exotoxin A 
shows similar pH dependency with Tm values of ~ 36 °C at pH 4 and ~ 56 °C at pH 
723. Identical transitions at acidic pH suggest a similar role for the PE structural 
transitions in acid triggered unfolding of the fusion protein.  
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Alanine scanning mutagenesis of α-helix D of IL-13 shows that presence of 
positively charged residues at the three key binding positions of 105, 106, and 109 
enhanced the avidity of IL-13 towards its receptor, IL13Rα218. It is therefore 
plausible that a complementary region in the IL13Rα2 receptor has a negatively 
charged character, raising the possibility of attractive electrostatic interactions 
between the two. In addition, pH dependent insertion/membrane binding studies of 
PE finds the transition pH increasing by about 0.8 units in the presence of anionic 
lipids in a model membrane system, presumably due to destabilization and enhanced 
unfolding of PE23. In general, polyanions are known to interact non-specifically with 
a variety of proteins24-32 and play a role in protein-protein interactions, protein folding 
and stabilization33,34. Our preliminary screening studies showed that the polyanion 
dextran sulfate was very effective in inhibiting protein aggregation but destabilized 
the fusion protein’s tertiary structure (reducing the Tm by ~ 10 °C, data not shown) 
suggesting such interactions to be in effect. The fusion protein behaved similarly in 
the presence of heparin in which the polyanion inhibited its aggregation by ~ two fold 
but destabilized its tertiary structure by reducing the Tm by ~ 7 °C (data not 
illustrated). The destabilizing effect of polyanions on the fusion protein is in 
agreement with the destabilizing effect of anionic lipids of the endosomal membranes 
on the toxin domain. Therefore, the effect of polyanions on conformational stability 
of this novel fusion cytotoxin should be studied further since such interactions have 
also proven to be essential for the proper functioning of a number of other 
macromolecular complexes35-40.  
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One similarity between the fusion protein and its toxin domain is the lack of 
any clear transitions in temperature dependent tryptophan peak shifts at pH values 
below 4. This is observed at pH 3 for the fusion protein (Fig 3.2a, 3.4a, and 3.4b) and 
at pH values below 3.7 for PE23. Jiang et al. show that PE undergoes a two step 
conformational alteration in the acidic pH range exhibiting two distinct 
conformational states23; an intermediate low pH folded state is observed in the pH 
range of 3.7-5.4 with very weak or no hydrophobicity followed by a second low pH 
unfolded-like conformation below pH 3.7 containing strong apolarity. The pH-
dependent behavior of the fusion protein suggests a similar highly disrupted 
conformation at acidic pH values. The fusion protein shows enhanced hydrophobicity 
as a function of decreasing pH in which the onset of ANS binding to apolar regions of 
protein shifts from ~ 40 °C at pH 5 to ~ 25 °C at pH 4. No clear transitions are 
observed at pH 3 presumably due to the presence of already structurally disrupted 
protein, in agreement with the behavior of the toxin domain. 
The tryptophan emission maximum of PE occurs at ~ 336 nm below pH 3.7, 
331 nm between pH 3.7 and 5.4, and 334 nm above pH 5.423. The fusion protein 
follows a similar trend in which Trp emission maxima were observed at ~ 332 nm at 
pH 3, ~ 330 nm at pH 4, and ~ 331 nm above pH 4 (calculated based on a direct peak 
picking method). The similar pH dependent emission peak shifts again suggest 
similar tertiary structural alterations between the two proteins. The magnitudes of the 
shifts are, however, smaller for the fusion protein, presumably due to the presence of 
IL-13 and the differences in stability between wild type PE and its derivative, PE4E. 
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Both circular dichroism and fluorescence spectroscopy studies show more thermally 
stable protein at pH values at or above neutral pH (Fig 3.1, 3.2, and 3.3) in agreement 
with optimal toxin enzymatic activity at more basic pH values20. Thus, the results 
presented here strongly suggest that the thermal stability of the fusion protein can be 
understood at least qualitatively as a summation of the transitions of its individual 
domains.  
Analysis of the secondary and tertiary structural alterations of the fusion 
protein suggests the presence of intermediate molten globule (MG) states across the 
pH range 5-8. Comparing the onset transition temperatures obtained from CD studies
(Fig 3.1b) to those of tryptophan peak position (Fig 3.2a) and ANS intensity (Fig 3.4a) 
shows that tertiary structure changes precede secondary structure alterations, a key 
characteristic of MG states. MG sates are often characterized by their extensive 
secondary structure, minimal tertiary structure, and a tendency to aggregate41. The 
importance of an acid-triggered unfolding event in membrane penetration ability of 
the toxin and considering the similarities in structural alterations between th fusion 
protein and its toxin domain presented here, it is plausible that qualitatively 
equivalent MG states play a role in the protein’s biological activity. Presence of such 
states might be essential for endosomal membrane penetration and translocation 
across such membranes. Studies of Sanyal and Gress42,43 on TP40, a fusion protein 
composed of transforming growth factor-α and a derivative of pseudomonas exotoxin, 
showed  presence of similar intermediate molten globule states. Although the 
secondary structural alterations of the fusion protein herein are more extensive 
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compared to those of TP40 and therefore nature of the molten globule states appear to 
be weakened, the results contribute to emerging view of involvement of MG states in 
facilitating membrane translocation of fusion cytotoxins.   
By further integration of the spectroscopic data into an empirical phase 
diagram, we were able to identify structural changes which served as a basis for 
screening of effective stabilizers. It is well known that a variety of potential additives 
such as sugars, amino acids, surfactants, salts and polyols can protect proteinsagainst 
chemical and physical degradation in both liquid and lyophilized formulations44-47. 
Our studies indicate that combinations of sodium citrate with dextrose, trehalos , or 
sorbitol are effective in both inhibiting the fusion protein aggregation as well as 
stabilizing its tertiary structure under accelerated degradation conditions (Tables 
3.2&3.3). The aggregation kinetic trace of the fusion protein (Fig 3.6) showed a 
characteristic lag time implying the existence of a critical nucleation-dependent 
aggregation event which has frequently been observed for a variety of other proteins 
47-50. These promising stabilizers proved to be effective in inhibiting the extent of 
aggregation but none showed the ability to lengthen the nucleation lag phase (not 
illustrated).  
Final concentration and combination of more promising stabilizers identified 
herein should be further optimized to provide a suitable liquid formulation compatible 
with the protein’s therapeutic application and its route of administration. Future 
studies are thus focused on evaluating and optimizing parameters such as ionic 
strength, osmolarity, and viscosity of the protein formulation and its integrity over its 
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shelf life upon addition of such excipients. The success of such potential formulations 
should be further examined in long-term stability studies which will provide a further 
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4.1. Introduction  
Acute infectious dehydrating diarrhea is the most common cause of morbidity 
and mortality among children resulting in more than five million annual deaths 
worldwide1. Viruses are recognized as the most important cause of this disorder2 with 
rotavirus as the most fatal etiologic agent in this category. It is alone responsible for 
more than half a million deaths annually3. Essentially all children under the age of 
five regardless of sanitation, socioeconomics, or geography are infected. The rate of 
mortality, however, differs dramatically between developed and developing countries 
with 85% of the deaths occurring in the poorest countries of Africa and Southeast 
Asia4.  
The epidemiologic characteristics associated with rotavirus recommend 
vaccination as the primary public health intervention. This is based on the observed 
similar morbidity rates in both developed and developing countries. Moreover, 
existing high hospitalization rates suggests that neither improved sanitation nor the 
available oral rehydration therapies can effectively prevent rotavirus-related 
gastroentritis. Extensive studies, however, suggest that mild asymptomatic infections 
effectively protect against subsequent severe rotavirus infections indicatg the use of 
a vaccine which produces mild infections5.   
The first rotavirus vaccine, Rotashield by Wyeth-Lederle, was introduced in 
the United States in 19986. A serious complication (i.e. intussusception, a fatal bowel 
obstruction) associated with this tetravalent human-bovine reassortant vaccine, 
however, resulted in its withdrawal from the market less than a year later7. Th  next 
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generation of rotavirus vaccines, the GlaxoSmithKline’s monovalent vaccine, 
RotaRix8, and Merck’s pentavalent human-bovine reassortant vaccine, RotaTeq9, 
were introduced in 2005 and 2006 respectively. These vaccines have already had a 
dramatic effect on rotavirus induced disease and mortality in the developed world. 
The complications and high costs associated with the distribution of these vaccines in 
developing world, however, have limited their use in the poorest countries of Africa 
and Southeast Asia where the highest rates of rotavirus mortality reside. Ther fore, a 
need for a third generation of rotavirus vaccines targeted towards the developing 
world still exists.      
One major complication in the development of vaccines for mass 
immunization, particularly in the developing world, is creation of a vaccine 
formulation that can be stored and remained biologically active over the entire 
required shelf life of 24 months at as high a temperature as possible. The main 
antigenic component of vaccine formulations is some form of the infective virus, 
either killed or live but attenuated. Virus particles are large macromolecular 
complexes10 with inherent thermolability which is responsible for lack of optimal 
vaccine stability11-16. Storage at refrigerated temperatures or as lyophilized 
formulations is generally required for retaining the stability and efficacy of vaccines. 
This can, however, introduce significant difficulties in their storage, shipment, and 
delivery. Due to insufficient technological support including lack of refrigerators and 
frequent power failures, vaccines can be exposed to elevated temperatures for 
extended periods of time. This has traditionally resulted in wastage of approximately 
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half of the supplied vaccines17. Thus, there is a need for thermally stable vaccine 
formulations.  
The traditional approach to evaluating vaccine efficacy has been by means of 
measuring the production of antibodies in animal models in response to vaccine 
administration. Although this method provides information regarding the efficacy of 
the vaccine formulation, it forces an essentially empirical approach to impr ve 
stability. Biophysical studies on the other hand have the potential to provide insight 
into the mechanisms of inactivation of a viral vaccine as a function of a variety of 
environmental conditions. Herein, we have employed a variety of spectroscopic 
techniques (i.e., circular dichroism, fluorescence spectroscopy, and static and 
dynamic light scattering) for a comprehensive examination of the thermal stability of 
three live-attenuated human-bovine reassortant rotavirus strains (G1, G3, and G4) 
over a wide pH range (i.e. 5-8). The three serotypes examined, classified based on the 
molecular composition of their outer coat viral glycoprotein, VP7 18, are ideal vaccine 
candidates. These strains are the most infectious in their family accounting for ~ 70% 
of all human rotavirus infections worldwide19. In addition, the already marketed 
rotavirus vaccine, Merck’s RotaTeq, includes these three strains. This vaccine has 
been shown to provide a synergistic immunological response effective against each 
individual strain9. The major issue we address here is whether the methods we 
employ which produce results that are averaged over the entire virus structure, can 
detect destabilizing events which can be used to produce more stable formulations.  
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4.2. Materials and Methods 
4.2.1. Sample Preparation  
The purified bulk rotavirus samples were stored at -80 °C in 11 mM potassium 
phosphate buffer, pH 7.2, containing 7.22% sucrose for improved long term storage. 
Samples were thawed at room temperature and were concentrated ten fold employing 
an Amicon stirred ultrafiltration cell (model 8400) for spectroscopic studies. The 
samples were then buffer exchanged into 20 mM isotonic citrate phosphate buffer 
ranging from pH 5 to 8, at one pH unit intervals (the isotonicity was maintained using 
sodium chloride). Exchange of the viral stock solutions into citrate phosphate buffer 
below pH 5 resulted in aggregation of the viral particles and therefore was not used in 
our studies. For buffer exchange, rotavirus samples were dialyzed at refrigeration 
temperatures using a Spectra/Por molecular porous membrane tubing (SpectrumLab, 
Rancho Dominguez, CA) with a 15KDa MW cutoff. The concentration of the 
samples after dialysis was determined by BCA assay (Pierce, Rockford, IL). Samples 
at a concentration of 100 µg/ml were used for all spectroscopic studies with the 
exception of CD and dynamic light scattering in which concentrations of 200 and 50 
µg/ml were employed, respectively. For all spectroscopic studies, three ind pendent 
samples were evaluated to ensure reproducibility of the measurements. A virus
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4.2.2.  Far-UV Circular Dichroism (CD) Spectroscopy 
CD spectra were acquired using a Jasco J-810 spectropolarimeter equipped 
with a 6-position Peltier temperature controller. The CD spectra were obtained from 
260-190 nm at a scanning speed of 20 nm/min, a 2 second response time and an 
accumulation of 3. To study thermal transitions (melting curves) of the rotavirus, the 
CD signal at 222 nm was monitored in 0.1 cm pathlength cuvettes every 0.5 °C over a 
10 to 85 °C temperature range employing a temperature ramp of 15 °C/hr.  
 
4.2.3. Intrinsic Tryptophan (Trp) Fluorescence Spectroscopy 
 Fluorescence spectra were acquired using a Photon Technology International 
(PTI) spectrofluorometer (Lawrenceville, NJ) equipped with a turreted 4-position 
Peltier-controlled cell holder. An excitation wavelength of 295 nm was used to excite
Trp and the emission spectra were collected from 300 to 400 nm with a step size of 1 
nm and 1 sec integration time. Excitation slits were varied over the pH range. 
Therefore, both the fluorescence intensity and light scattering data were normalized 
with respect to the initial reading at 10 °C for comparison purposes. Emission spectra 
were collected every 2.5 °C with a 3 min equilibration time over a temperature ng  
of 10 to 85 °C. A buffer baseline was subtracted from each raw emission spectrum.  
 
4.2.4. Dynamic Light Scattering  
The hydrodynamic diameter of the viral particles was analyzed using a 
dynamic light scattering instrument (Brookhaven Instrument Corp., Holtzille, NY) 
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equipped with a 50 mW diode-pumped laser (λ = 532 nm). The scattered light was 
monitored at 90° to the incident beam, and autocorrelation functions were generated 
using a digital auto-correlator (BI-9000AT). Data were collected continuously for 
five 30-seconds intervals for each sample and averaged.  The hydrodynamic diameter 
was calculated from the diffusion coefficient by the Stokes-Einstein equation using 
the method of cumulants20. The instrument was equipped with a temperature-
controlled circulating water bath (RTE111, Neslab, Newington, NH) and the 
hydrodynamic diameter was monitored over a temperature range of 10 to 85 °C. 
 
4.2.5. Transmission Electron Microscopy 
Electron microscopy imaging of uranyl acetate-stained rotavirus strain  was 
performed to analyze structural alterations due to changes in pH and temperature. 
Briefly, rotavirus samples were dialyzed into 20 mM isotonic citrate phosphate buffer 
at pH 5 and 7 for about 16 h at refrigeration temperature. The dialyzed samples were 
recovered and conformational changes were analyzed under variable temperatures by 
negatively staining with uranyl acetate and viewed with a Tecnai G2 transmission 
electron microscope (FEI Company, Hillsboro, OR). Rotavirus samples at 60 µg/ml 
were placed into small vials and incubated in a water bath.  Vials were heated from 
10 to 90 °C at a ramp rate of 15 °C / hr.  At 4, 40 and 70 °C, virus samples (20 µl)
were collected and were immediately placed onto the carbon-coated grids (Electron 
Microscopy Sciences, Hatfield, PA) for 2 min.  After washing with three consecutive 
drops of distilled water, the grids were then placed into 2% uranyl acetate for 1 min.  
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The extra stain was removed by blotting with tissue paper.  The wet grids were 
allowed to air-dry for at least 48 hours prior to being examined by the TEM.  
 
4.2.6. Fluorescence Focus Assay  
The assay plates were prepared with a monolayer of MA-104 cells in flat-
bottomed 96-well assay plates at 10,000 cells per well (200 µL cell suspension per 
well). The plates were stored in a humidified 37 °C incubator, 5% CO2 for 3-5 days 
until a confluent monolayer was reached (i.e., 4th day post plating). The old media 
was replaced with fresh MEM on the day of the assay. The virus samples were 
activated with 5 µg/mL trypsin (final concentration) for one hour in a humidified 
37 °C incubator (5% CO2). Serial dilutions (1:4) of the virus samples were made in 
duplicate in a separate 96-well dilution block allowing one well as cell control for 
each sample. 50 µL of the diluted samples were transferred to the 96-well assay pl te 
containing 150 µL MEM per well. The assay plates were stored in a humidified 36 °C 
incubator (5% CO2) for 18 hours. The cell monolayer was washed with MEM post-
incubation and fixed with 80% Acetone for 20 minutes at -20 °C. 50 µL of the diluted 
primary (i.e., rabbit polyclonal) antibody was added to each well of the 
assay plate and incubated at 37 °C for 60 min.  The secondary (i.e., goat anti-
rabbit IgG (H + L), biotinylated) antibody at 50 µL/well was added 
after washing the cell monolayer with Tween PBS (0.5% Tween 20 in PBS). 
The plates were incubated at 37 °C for another 60 min and then washed with TPBS. 
The Alexa Fluor 488 Streptavidin conjugate was added at 50 µL/well and incubated 
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at 37 °C for 60 minute and finally washed with Tween PBS. To avoid bleaching, the 
stained assay plates were wrapped with foil and stored in a 4 °C refrigerator. 
Fluorescent cells were imaged under a microscope with an appropriate filter and lamp. 
The fluorescent cell forming units per mL were calculated based on the count of the 
fluorescent cells, the dilution used, the magnification, and the total surface are. The 
titer is an average of the two duplicate assays performed on one sample. 
 
4.2.7. Empirical Phase Diagrams (EPDs)  
 Empirical phase diagrams were constructed employing CD, intrinsic Trp 
fluorescence peak position, and static and dynamic light scattering data. All 
calculations were performed using Matlab software (The MathWorks, Natick, MA). 
In brief, the normalized experimental data at each coordinate (i.e., at specific 
temperature and pH combinations) are first converted into an N-dimensional vector, 
where N refers to the number of variables included (i.e., number of different types of 
data). The complex data sets from all measurements are now defined as multi-
dimensional vectors in a pH/temperature phase space. The projectors of each
individual vectors are then calculated and summed into an N × N density matrix. By 
definition, an N × N matrix has N sets of eigenvalues and eigenvectors. The 
individual vectors at each coordinate are truncated into 3-dimensional vectors and re-
expanded into a new basis set consisting of the three eigenvectors corresponding to 
the three largest eigenvalues. The resultant 3-dimensional vectors are then conv rted 
into a color plot with each vector component corresponding to a color using an 
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arbitrary RGB (red, green, blue) color scheme. Details of the mathematical theory and 
calculation process can be found elsewhere21.  
 
4.3. Results 
4.3.1. Far-UV Circular Dichroism (CD) Spectroscopy  
Alterations of rotavirus secondary structure were studied by monitoring the 
changes in the CD signals as a function of pH and temperature. Each serotype shows 
a distinct pH dependence of its secondary structure content (Fig 4.1). All of the 
spectra display the well recognized signature of α-helix, a double minima at 208 and 
222 nm. With the exception of G4 at pH 8, the intensity of the CD ellipticity at 222 
nm is greater or equal to the signal at the lower wavelength. This is consistent with a 
significant content of β-structure in almost all cases. What is most distinctive about 
the results is that the CD spectrum of each of the 3 serotypes responses differntly to 
pH. This is most clearly seen at pH 6 where G1 demonstrates the least intense 
spectrum in contrast to the other pH values. Because of the low quality of the data 










































































































Figure 4.1.CD spectra of three rotavirus strains at various pH values. CD pectra were 
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The effect of temperature on the rotavirus secondary structure was further 
investigated employing thermal melt analysis (Fig 4.2). The destabilizing effect of 
increasing temperatures on rotavirus secondary structural stability is indicated by an 
overall loss of the secondary structure content of all three strains over the pHrange 
examined. The transitions at pH 5 are all very gradual. Following this initial gradual 
transition, strains G1 and G3 exhibit a much sharper transition at higher temperature 
centered near 75 °C. At pH 6, G1 and G4 show biphasic behavior with the first 
transition onset temperatures at ~ 37.5 and 50 °C, respectively. A later transition is 
observed at ~ 75 °C for both strains. At this pH, the G3 strain shows a gradual 
transition at lower temperatures followed by a sharp transition which begins at ~ 
70 °C. All three strains show biphasic behavior at pH 7 with the earlier transitions 
occurring at ~ 40, 45, and 47.5 °C for G1, G3, and G4, respectively. Again, a later 
transition at ~ 70 °C for G1 and G3 and ~ 75 °C for G4 is observed. The G3 strain 
exhibits biphasic behavior at pH 8 with a gradual transition at low temperatures 
followed by a later transition with an onset at ~ 70 °C. Early transitions at ~ 35 and 
40 °C for the G1 and G4 strains is followed by a second transition at ~ 65 and 70 °C 
respectively. Overall, the G4 strain shows higher thermal stability compared to the 
other two strains in terms of thermally induced changes in CD signals. The onset of 
the early transitions is lowered as the pH is increased over the range of 6 to 8, 
suggesting reduced thermal stability as a function of increasing pH. 
 
 
































   











































   























Figure 4.2.The effect of temperature on the secondary structure of rotavirus strain at 
different pH values. Signal at 222 nm was monitored as a function of temperature 
over the pH range 5–8 (n = 3).  
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4.3.2. Intrinsic Tryptophan (Trp) Fluorescence Spectroscopy  
Alterations in the rotavirus tertiary structure were studied by monitoring 
changes in the Trp emission peak position as a function of pH and temperature. An 
overall red shift in the Trp emission maximum is observed as a function of increasi g 
temperature over the pH range examined (Fig 4.3) suggesting enhanced exposure of 
the indole side chains to solvent upon conformational alterations. The magnitude of 
the red shifts at pH 5 is smaller for all the strains compared to higher pH. Over the pH
range of 6-8, a gradual red shift at low temperatures is observed for all the strains
followed by sharper transitions at higher temperature. The onsets of the higher 
temperature transition are similar among the three strains and occur at ~ 67.5 °C at 
pH 6, 62.5 °C at pH 7, and 55 °C at pH 8, indicating decreased tertiary structure 
stability as a function of increasing pH and in direct agreement with the CD studies. 
G3 exhibits the largest red shifts of ~ 9-10 nm over the pH range of 6 to 8 suggesting 
more pronounced unfolding events for this strain. The extent of temperature-induced 
exposure of indole side chains to solvent is similar for the G1 and G4 strains over this 
pH range with red shifts of ~ 4-5 nm in magnitude. The initial peak positions near 
330 nm suggest that on average, the indole side chains of the Trp residues in the viral 
particle are buried in a fairly apolar environment. The temperature dependent Trp 
fluorescence intensities exhibited no distinct transitions from pH 5 to 8 and only a 
curvilinear decrease due to the intrinsic thermal quenching of the fluorescenc sig als 
was observed (data not shown).  
 




























   
















































   
























Figure 4.3.Tryptophan emission peak position as a function of pH and temperature. 
Rotavirus solutions at pH 5–8 were heated from 10 to 85 °C, and the fluorescence 
emission maxima were monitored (n=3) upon excitation at 295 nm.   
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4.3.2.1. Static Light Scattering 
The aggregation behavior of the rotavirus strains was simultaneously 
examined by monitoring the scattered light at the wavelength of flu rescence 
excitation (Fig 4.4). Complex, multi-phasic behavior is observed for all str ins across 
the pH range examined. At pH 5, the G3 and G4 strains show multiple weak 
transitions possibly due to the formation of micro-aggregates and soluble oligomers. 
A much sharper transition is observed for the G1 strain at ~ 40 °C. At pH 6, both the 
G3 and G4 strains exhibit an early transition at ~ 42.5 °C and a later one at ~ 67.5 and 
70 °C respectively. The G1 strain manifests a significant transiio  at ~ 35 °C. At pH 
7, G3 shows no distinct early transitions, and only a weak one at ~ 70 °C while G4 
shows multiple transitions at ~ 45 and 70 °C. The G1 strain shows similar behavior to 
that at pH 6 with the onset of the transition observed at ~ 35 °C. At pH 8, the G1 and 
G4 strains show a weak transition at ~ 60 °C while G3 shows no significant 
transitions (Fig 4.4). Overall, the G1 strain shows more pronounced transitions 
suggesting a greater propensity for the formation of soluble oligomers at lower 
temperatures. This can lead to more extensive aggregation as a function of increasing 
temperatures as suggested by the dynamic light scattering data (see below). Decreases 
in scattering intensity probably reflect particle swelling since the refractive index 

































   






















































   




























Figure 4.4.Static light scattering as a function of pH and temperature. Rotavirus 
solutions at pH 5–8 were heated from 10 to 85 °C, and the scattering intensity was 
monitored at 295 nm (n=3).  
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4.3.3. Dynamic Light Scattering  
Alterations in the quaternary structure of rotavirus were studied by monitoring 
its DLS measured hydrodynamic diameters as a function of pH and temperature (Fig 
4.5). The hydrodynamic diameters were calculated from diffusion coeffi ients using 
the Stokes-Einstein equation and the method of cumulants23. The onset of transition 
temperatures occur at ~ 45 °C for all three strains at pH 5. The rate of increase in the 
hydrodynamic diameter, however, appears to occur more rapidly for G1 compared to 
the other two strains. At pH 6, all three strains exhibit biphasic transitions in size with 
early onsets at ~ 45, 47.5, and 50 °C for G1, G3, and G4, respectively. The second 
transition occurs at ~ 67.5 °C for G1 and G3 and 72.5 °C for the G4 strain. The G1 
and G4 strains also exhibit biphasic behavior at pH 7 in which early tr nsi ion onsets 
are observed at ~ 50 and 55 °C followed by a second transition at ~ 77.5 °C. The G3 
strain shows an onset transition at ~ 65 °C at pH 7. At pH 8, this biphasic behavior 
continues in which early onset transitions occur at ~ 47.5, 57.5, and 55 °C followed 
by later transitions at 72.5, 75, and 77.5 °C for the G1, G3, and G4 strains, 
respectively. Overall, the onset of size increase is similar for a given strain over the 
pH range examined with the exception of G3 which exhibits a detectably higher onset 
transition temperature at pH 7. The G1 strain exhibits higher aggregation r tes over 
the pH range examined as manifested by more rapidly increasing rates of its average 
size.     
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Figure 4.5.Analysis of the size of rotavirus strains as a function of pH and 
temperature. Data analysis was performed using the method of cumulants. The data 
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The hydrodynamic diameters based on the method of cumulants are larger 
than the typical rotavirus size of ~ 70-100 nm (Fig 4.5). This discrepancy can be 
further examined using a non-negatively constrained least square (NNLS) analysis of 
the DLS data. This algorithm is often used when studying heterogeneous samples 
with multimodal size distributions in which the autocorrelation function is 
deconvoluted to yield size distributions22. For example, the NNLS analysis of the 
higher order species (< 1%) at pH 7 and 10 °C reveals particles approximately fifte n, 
four, and three times larger than the monomeric species for G1, G3, and G4, 
respectively (data not shown). The presence of the higher molecular weight species 
clearly accounts for the elevated sizes observed by the cumulants method and also for 
the differences observed in size among the three strains at 10 °C. In addition, the 
NNLS analyses of the three strains at 10 °C reveal that more than 99% of the viral 
particles possess a size of ~ 70-120 nm, consistent with the expected rotavirus size. 
The variations in size (i.e., the wide 50 nm range) observed when using the NNLS 
method are presumably due to heterogeneity of the samples (polydispersity index 
values > 0.2).  
 
4.3.4. Activity Measurements  
The activity of the individual strains at pH / temperature combinations 
corresponding to the distinct physical states identified in the EPD (see below) was 
examined using a Fluorescence Focus assay (Table 4.1). At 4 °C, the G1 strain 
exhibits the highest activity at both pH 5 and 7 followed by the G3 and G4 strains in 
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which the latter appears to be the most prone to pH inactivation at refrigeration 
temperatures. At pH 5, all of the strains retain their activity when the temperature is 
increased to 40 °C. At pH 7, however, the activity is lost suggesting a damaging 
effect of higher pH values under thermally induced degradation conditions. Finally, at 


























Strain G1 G3 G4 
Temp / pH pH 5 pH 7 pH 5 pH 7 pH 5 pH 7 
4 °C 7.19 ± 0.015 7.44 ± 0.012 7.16 ± 0.052 7.14 ± 0.108 6.81 ± 0.107 7.13 ± 0.003 
40 °C 7.09 ± 0.046 bdl* 7.28 ± 0.081 bdl 6.66 ± 0.051 bdl 
70 °C bdl bdl bdl bdl bdl bdl 
 
Table 4.1. Rotavirus strain activities upon exposure to different pH / temperature 
conditions. Activity is measured using a fluorescence focus assay (see methods) and 
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4.3.5. Transmission Electron Microscopy 
As an additional tool to enhance interpretation of the spectroscopic results, 
EM studies were employed as a function of pH (5 and 7) and temperature (4, 40, 
70 °C) to cover a range of distinct physical states identified in the EPDs of the three 
strains (Fig 4.6). The strains are used interchangeably here since the EM analysis did 
not recognize any detectable differences among the three strains at different pH / 
temperatures combinations, in agreement with the EPD results (see below). At 4 °C, 
both pH 5 and 7 exhibit dominantly infectious, triple layer particles along with a 
small population of particles with disrupted outer layer capsids (Fig 4.6a & 4.6d, 
respectively). At pH 5 and 40 °C, triple layer particles still appear to be dominant (Fig 
4.6e). At pH 7 and 40 °C, however, most particles appear to have disrupted outer 
layers (Fig 4.6b) which can explain the loss of activity at this pH / temperature 
combination. At pH 7 and 70 °C (Fig 4.6c), EM images show primarily clusters of 
particles and aggregated sheets in agreement with the scattering data (the d ta at pH 5 
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b) pH 7 / 40 °C     
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d) pH 5 / 4 °C     
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e) pH 5 / 40 °C     
 
Figure 4.6.Electron microscopy images of rotavirus as a function of pH and 
temperature.  
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4.3.6. Empirical Phase Diagrams (EPDs) 
The spectroscopic data for each strain were integrated into an empirical phase 
diagram to provide a more global picture of the virus response to temperature and pH 
(Fig 4.7). In the EPD, regions of continuous color define uniform structural (non-
thermodynamic) states while abrupt changes in color identify alterations in the 
physical state of the rotavirus over the conditions examined. The properties of the 
rotavirus strain within each phase can be established by reference to the individual 
measurements. We emphasize that the EPDs should not be confused with classic 
thermodynamic phase diagrams in which equilibrium exists between different phases. 
At least partially irreversible aggregation as seen here prevents any such analysis. The 
EPD of each rotavirus strain clearly shows a number of distinct physical states over 
the pH and temperature range examined.   
G1. The green P1 phase across the pH range of 5 to 8 below ~ 40 °C is the region of 
maximum viral integrity with the virus particles dominantly in their intact triple layer 
conformations. The purple and brown phases labeled P2 at pH 5 and 6 between 60 
and 70 °C respectively contain some aggregates as manifested by the static and 
dynamic light scattering data at pH 5 and the dynamic light scattering rsults at pH 6. 
This phase at pH 6 also contains altered protein tertiary structure as indicated by 
shifts of the tryptophan peak position. The blue / purple region labeled P3 over pH 5 
and 6 above 70 °C contain further alterations of protein secondary structure compared 
to the P2 phase. The brown region labeled P4 contains aggregated particles. The 
pinkish P5 region contains particles with perturbed secondary and tertiary structures 
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along with more extensive aggregation. The brown region labeled P6 contains 
particles of altered secondary structure according to the CD thermal melt studies. 
G3. The brownish P1 phase across the pH range of 5 to 8 below ~ 40 °C is again the 
region of maximum stability. The bright green P2 phase is a region of minimum 
stability with perturbed secondary and tertiary structures and the presence of 
extensive aggregates. The intermediate P3 phase contains particles with perturbed 
tertiary structures. The light blue region labeled P4 at pH 5 contains extensive 
aggregates.   
G4. The green P1 phase across the pH range of 5 to 8 below ~ 40 °C is the region of 
maximum stability with the virus particles dominantly in their intact triple layer form. 
The dark green phase labeled P2 at pH 5 contains some aggregates as manifested by 
the DLS data. The brown P3 phase contains particles with altered secondary structure 
and some aggregates. The purple and red regions at pH 5 and 6 above ~ 70 °C contain 
more extensive aggregates with perturbed secondary and tertiary structures. The 
brownish region labeled P5 at pH 7 and 8 contains some aggregates as well as 
perturbed tertiary structure. The pinkish region labeled P6 contains protein with 
altered secondary and tertiary structure as well as extensive aggreg tes. 
Overall, the EPDs of the three strains show very similar behavior in terms of 
the strains’ global responses to variations in pH and temperature as suggested by th  
similar physical states identified. The EPDs of the G1 and G4 strains manifest sharper 
and clearer intermediate states, absent in the EPD of the G3 strain. Examination of the 
EPD of the three strains reveals distinct conformational and aggregation phases 
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across the pH and temperature range examined. The spectroscopic data suggest that 
all three strains are stable in the pH range of 5 to 8 below ~ 40 °C (the P1 phase in all 
three EPDs). This is supported by EM image analyses at low temperatures which 
reveal dominantly intact, triple layer infectious particles. All three strains show a 
region of minimum stability with perturbed protein secondary and tertiary structures 
along with the presence of aggregates in the pH range of 5 to 8 at elevated 
temperatures above 55 to 60 °C (P3&P5 phases in the G1 EPD, the P2&P4 phases in 
G3 EPD, and the P4&P6 phases in G4 EPD). The EM images further exhibit 
extensive aggregation at the more elevated temperatures of 70 °C. The onset 
temperatures at which the structural alterations occur are lowered in a stepwise 
fashion as a function of increasing pH, suggesting reduced virus thermal stability at 
increasing pH. This is supported by the stabilizing effect of lower pH on virus activity 
upon increasing temperatures from 4 to 40 °C (Table 4.1). At more moderate 
temperatures between 40 and 60 °C, the spectroscopic analyses show subtle and 
gradual alterations of the virus’s secondary and tertiary structures along with 
formation of micro-aggregates / soluble oligomers detected by the static ligh  
scattering data (the P4 and P6 phases in G1 EPD, P3 in G3 EPD, and P3 and P5 in G4 
EPD). The EM analyses at pH 7 and 40 °C further show intact, triple layer rotavirus 




































































Figure 4.7.Temperature / pH empirical phase diagrams of rotavirus strains G1, G3, 
and G4 based on intrinsic fluorescence, CD thermal melts, and static and dynamic 
light scattering data. A detailed description of the origin of the individual phases 
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4.3.7. Effect of Formulation Buffer 
Studies by Peterson et al. on the individual strains (G1, G2, G3, G4, P1) of the 
pentavalent human-bovine reassortant rotavirus vaccine, RotaTeq, suggest that the 
formulation buffer has major impact on virus activity. They suggest that increasing 
concentrations of citrate cause disaggregation of the virus particles presumably due to 
a carboxylic-acid mediated interaction with the surface charges of the virus 23. 
Dynamic light scattering studies showed a decrease in virus size as a function of 
increasing citrate concentration. Figure 4.8 is the initial portion of the DLS thermal 
curves over the temperature range of 10-30 °C in the absence of any major structural 
alterations as suggested by the collective spectroscopic data. Detectably sm ller 
particle sizes are observed at pH 5 compared to pH 7 for the G1 and G3 strains in 
agreement with the studies of Peterson et al. This can be explained as due to the 
presence of citrate ions at three fold higher concentrations at pH 5 compared to pH 7. 
Although G4 exhibits a smaller size compared to the other two strains, it does not 
show any pH dependent citrate-mediated effect. 
The two surface proteins, VP4 and VP7 are presumably involved in 
electrostatic interactions with the buffer ions. Estimation of the charge on the human 
G1 strain’s VP7 protein (PDB # ABI63532) shows a net negative charge of ~ -0.6 and 
-8.1 at pH values 5 and 7, respectively. Similar analysis of the VP4 protein of the 
human G1 Wa strain24 finds VP4 net charges of ~ 20.6 and -1.2 at pH values 5 and 7, 
respectively. The net negative charges on both proteins at pH 7 are repulsive for 
electrostatic interactions with the buffer anions in agreement with the less pronounced 
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citrate mediated mechanism observed. At pH 5, however, the VP4 protein possesses a 
highly net positive charge, suggesting its dominant role in the proposed electrostatic 
interactions. Such charge behavior, however, cannot explain the much weaker citrate 
effects on G4 since it possesses a very similar surface net charge as the other two 



























































Figure 4.8.Analysis of the size of rotavirus strains as a function of pH and 
temperature. Data analysis was performed using the method of cumulants. The data 
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4.4. Discussion 
Viruses, the main macromolecular ingredients of many vaccine formulations 
are thermolabile and are often destroyed either due to excessive heat (e.g., measles, 
polio) or freezing (e.g., tetanus, diphtheria). Therefore, development of thermostable 
vaccine formulations resistant to temperature excursions has major benefits. These 
include reducing vaccine wastage, increasing vaccine effectiveness, reducing 
dependency on the cold chains and related equipments, and enabling vaccine delivery 
to remote populations25. 
   The typical vaccine shelf life of 24 months typically requires long and 
expensive stability studies to determine the effect of different formulation parameters 
on vaccine stability. Accelerated stability studies are therefore routinely employed to 
screen formulations for their potential to meet or exceed stability goals. Herein, we 
have employed such an accelerated approach using a variety of spectroscopic 
techniques (i.e., circular dichroism, intrinsic fluorescence, and static and dynamic 
light scattering) to characterize the thermal stability of three liv  attenuated human-
bovine reassortant rotavirus strains as potential vaccine candidates. Liquid 
formulation of live-attenuated viruses, as is the case here, is often considered to be the 
most desirable type of vaccine formulation. This is due to both the ability to stimulate 
long lasting humoral and cellular immune responses16 as well as reducing 
complicating factors involved with lyophilized vaccine formulations 26-28. 
Studies by Meng et al. on the human serotype 1 (FH432) and simian agent 11 
(SA11) rotavirus strains show a destabilizing effect of pH and temperature variations 
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on virus activity29. At refrigeration temperatures, the activity of both strains is 
retained in the pH range of 3-10 while higher or lower values result in partial or 
complete loss of virus activity. These results are in agreement with the accel r ted 
studies at low temperatures (i.e., 10 °C) in which the virus activity is retained at both 
pH values of 5 and 7. Studies of Meng et al. showed that both strains lost activity 
upon very short incubations (i.e., a few minutes) at temperatures at or above 50 °C 
consistent with our accelerated stability studies at elevated temperatures (examined at 
70 °C) in which the activity of all strains is completely lost regardless of the pH. The 
extensive secondary and tertiary structural alterations as well as formati n of 
aggregates observed by both the spectroscopic and EM studies are presumably 
responsible for the loss of activity observed. Variations in pH have a major impact on 
virus activity when moderately raising the temperatures (i. ., to 40 °C) in which all of 
the strains retain activity at pH 5 but not at pH 7. Considering that the two antigenic 
surface proteins, VP4 and VP7 are responsible for the attachment and entry of the 
virus into the cells1,30, the increasing number of virus particles with partially disrupted 
outer layers in the EM images can explain such activity losses.  
The two antigenic proteins, VP7 and VP4 are believed to dominate the 
differences in the observed spectroscopic signals among the three strains. This i  
presumably due to both their spatial arrangement on the most outer layer of the virus 
and their abundance (2nd and 3rd respectively) in the rotavirus particle34. Although the 
intermediate layer protein, VP6 is the most abundant protein, it is part of the bovine 
core shared among all the three reassortants. The genome comprises about 15% of the 
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virus’s total mass and as observed in Figure 1, does not contribute detectably to the 
signals observed (no significant absorbance at ~ 260 nm).  
It can therefore be proposed that the structural alterations observed herein 
should directly impact virus activity. At pH 5, the G4 strain with the least amount of 
secondary structure shows reduced activity compared to the other two strains. At pH 
7, G1 shows the highest activity in agreement with its more extensive secondary 
structure content. At this pH, the G3 and G4 strains possess similar amounts of 
secondary structure and activity values. Activity data suggest that G3 is the least 
sensitive strain to pH variations in agreement with its rather pH insensitive secondary 
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Figure 4.9.CD spectra of rotavirus strains at pH 5 and 7. CD spectra were recorded at 
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The effect of tertiary structure alterations on virus activity appear to be less 
significant with subtle alterations in the low to intermediate temperature range 
exhibited  by the small red shifts in tryptophan peak position (Figure 3).  
Both of the currently available rotavirus vaccines are administered orally, 
exposing the virus to the acidic pH of the stomach (i.e., pH 2 to 6). An optimal 
rotavirus vaccine formulation should therefore be able to protect the virus against 
such harsh acidic environments. The EPD analysis of the three rotavirus strains shows 
induced thermal stability as a function of decreasing pH. Moreover, the stabilizing 
effect of lowering pH on virus activity is observed in which increasing temperatur s 
from 4 to 40 °C resulted in loss of virus activity at pH 7 but not at pH 5. These 
observations encourage formulations at lower pH values suitable for oral 
administrations. Dialysis of the virus bulk samples into citrate phosphate buffer below
pH 5, however, resulted in aggregation of viral particles suggesting the need for a 
stabilizing agent in the vaccine formulation. The commercially available RotaTeq 
formulation using similar citrate phosphate buffers contains sucrose as a stabilizing 
agent.  
Analyses of the individual spectroscopic techniques reveal detectable 
differences in the thermal stability of the three strains. Analyzing the EPDs, however, 
suggest that the global response of the strains to variations in pH and temperature is 
similar as manifested by the similar apparent pseudo-phase boundaries in the EPDs. 
The EPD approach therefore suggests similar stabilization strategies for all the strains 
and the feasibility of inclusion of multiple strains in a single rotavirus vaccine 
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formulation as has already been demonstrated in the commercial vaccines. The EPD 
approach has been successfully employed in the past for formulation of vaccines due 
to its ability to identify regions of marginal stability which can serve as a basis for the 
design and development of high throughput excipient screening assays15,32,33. The 
EPD approach has been further used for the biophysical characterization of a variety 
of other macromolecular systems and as a tool for the stabilization of such 
complexes21, 34-38.  
 
4.5. Conclusion 
The complexity associated with viruses and rotavirus in particular, may 
appear to decrease the utility of biophysical measurements in the analyses of such 
complicated systems. Although the information obtained are complex and 
interpretations at the molecular level is difficult, the results can still be used to detect 
stability changes due to the distinctive and highly reproducible signals produced. 
Rotavirus exhibits well defined size and shape by dynamic light scattering. In 
addition, spectroscopic techniques such as CD and fluorescence generated 
reproducible results across the pH and temperature range examined. Thus, these 
studies suggest that the EPD approach is potentially an effective tool in the early 
development of thermostable vaccine formulations based on the observation that 
alterations in selected physical parameters reflect losses in virus activity, a key 
parameter in design and development of such vaccines.           
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5.1. Introduction 
In the past, proteins were often perceived as relatively static structures based 
on their X-ray analysis. It is now well accepted, however, that proteins are highly 
dynamic molecules exhibiting a wide variety of different types of motions. Protein 
dynamic behavior plays a crucial role in their structural stability, folding, and 
biological functions1 and such motions are strongly coupled to solvent mobility2.   
 A variety of biophysical methods have been used to measure various aspects 
of protein structure from which dynamic behavior can be inferred. These techniques 
include isotope (H/D) exchange monitored by infrared spectroscopy, mass 
spectrometry, and nuclear magnetic resonance (NMR) spectroscopy as well other 
methods such as red edge shift spectroscopy, solute fluorescence quenching, 
ultrasonic spectroscopy, pressure perturbation calorimetry and molecular dynamics 
simulations. Here, for the first time, we examine the utility of the temperatur  
dependent 2nd derivative absorbance signals of protein aromatic amino acids as a 
qualitative probe of intramolecular dynamics.  
The application of UV absorption spectroscopy to proteins was initiated more 
than half a century ago at relatively low resolution3. Proteins display a broad peak in 
the 250-300 nm region of the ultraviolet spectrum composed of multiple overlapping 
bands from the aromatic residues phenylalanine, tyrosine, and tryptophan due 
primarily to π → π* transitions involving the electrons of their aromatic rings4. Due 
to the extensive overlap of these absorption peaks, the utility of UV absorption 
spectroscopy in protein analysis was, however, quite limited. Recent advances in 
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instrumentation, in particular the availability of diode array detectors and computer 
based derivative absorbance5, it is now possible to resolve the absorption bands of 
each of the three aromatic residues into multiple peaks with a resolution of 
approximately 0.01 nm. This provides a very sensitive tool with which to probe 
protein conformational alterations. 
Upon protein structural changes, the polarity of the microenvironment 
surrounding the aromatic side chains and their level of exposure to the surrounding 
solvent can be detectably altered. By monitoring the individual shifts of the derivative 
peak position of these residues, fairly detailed information can be obtained regarding 
the conformational alterations of proteins as a function of variety of conditions such 
as pH, temperature, ionic strength, etc. Using high resolution 2nd derivative UV 
spectroscopy, shifts in peak positions as small as 0.5 nm and as large as 6 nm have 
been monitored and correlated with protein structural alterations5-8.  
The temperature dependence of 2nd derivative peak shifts of the aromatic 
residues has been widely employed as a tool to probe protein thermal unfolding. In 
this case, shifts to lower wavelength (i.e., blue shifts) as a function of increasing 
temperature are often indicative of enhanced exposure of aromatic residues to solvent. 
In contrast, peak shifts in pre-transition regions below detectable unfolding evets 
have received no attention. Here, we demonstrate that plots of the temperature 
dependent 2nd derivative peak positions of the aromatic residues have measurable 
slopes in protein pre-transition regions. We have investigated the nature of these 
temperature dependent spectral alterations as a function of solvent physical properties 
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and provide evidence that such alterations can be used qualitatively to probe protein 
dynamics.  
It is worth mentioning that we have previously attempted related analyses b 
employing the spectral shifts induced by cation (Na+, Li+, Cs+)-π interactions as a 
function of increasing cation concentration4. By analogy to solute-based fluorescence 
quenching of proteins, it was generally found that small cations were more effectiv  
at reducing spectral shifts due to their ability to diffuse through a protein’s matrix and 
make contact with the aromatic side chains. In some cases, however, specific 
interactions between the cations (and perhaps accompanying counter anions, Cl-) 
made interpretation of the data difficult in terms of dynamic effects. Thus, a method 
that does not require the presence of potentially perturbing solutes, but rather involves 
a simple intrinsic effect such as temperature seems desirable.   
 
5.2. Materials and Methods 
5.2.1. Materials 
Ribonuclease T1 purified from Aspergillus oryzae was obtained from 
Epicentre (Madison, Wisconsin). N-acetyl-L-phenylalanine ethyl ester, N-acetyl-L-
tryptophan ethyl ester, N-acetyl-L-tyrosine ethyl ester, melittin, Substance P, Leucine 
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5.2.2. Sample Preparation 
To investigate the intrinsic effect of pH and temperature on UV spectral peaks, 
model amino acids N-acetyl-L-phenylalanine ethyl ester, N-acetyl-L-tyrosine ethyl 
ester and N-acetyl-L-tryptophan ethyl ester were dissolved in 20 mM citrate phosphate 
buffer, pH range of 3-8 at one pH unit intervals at final concentrations of 510, 146, 
and 37 µM, respectively. All peptide and protein samples were prepared by dialysis 
against 20 mM citrate phosphate buffer, pH 7.0 at refrigerated temperatures. The final 
pH of the protein samples were confirmed to ensure that the pH was within 7.0 ± 0.05. 
The effect of solvent dielectric constant and viscosity (both of which are 
temperature dependent) were also explored as potential sources of the spectral
alterations of the aromatic side chains. Solutions of aromatic amino acid analogs were 
prepared in a number of different organic solvent-water mixtures in which titration of 
organic solvents in water was used to mimic thermally induced changes of water 
dielectric and viscosity values over the temperature range of 25-60 °C. The dielectric 
constants and viscosity of the mixtures were determined as the sum of the mole 
fraction of each component times the dielectric constant and viscosity of the neat 
liquid, respectively. Prior to absorbance measurements at 25 °C, all samples were 
incubated at that temperature for five minutes, sufficient to reach thermal equilibrium. 
 
5.2.3. Absorbance Measurements and Data Analysis 
High resolution absorbance spectra were obtained over a temperature range 
(10-60 °C) employing an Agilent 8453 UV-visible spectrophotometer equipped with a 
 - 160 -
diode array detector and Peltier t mperature controller (HP 89090A). All samples 
were analyzed in a quartz cuvette with a 1-cm path length. The temperature was 
allowed to equilibrate for 5 min prior to the acquisition of each spectrum, sufficient 
for equilibrium to be obtained. An integration time of 25 sec was used to obtain 
spectra with a high degree of precision and samples were analyzed over the 
wavelength range of 200-400 nm. Second-derivative spectra were calculated using a 
nine-point data filter and third-order Savitzky–Golay polynomial with Chemstation 
software (Agilent). A spline function was applied to the resulting spectra using 99 
interpolated points between each raw data point. This approach permits a resolution of 
0.01 nm to be obtained under optimal conditions5-7. All second-derivative spectra 
were exported to Origin software to determine peak positions. Results are reported 
with error bars representing the standard deviation of the mean from three 
independent measurements.  
 
5.2.4. Fluorescence Acrylamide Quenching  
Fluorescence spectra were acquired using a Photon Technology International 
(PTI) spectrofluorometer (Lawrenceville, NJ) equipped with a turreted 4-position 
Peltier-controlled cell holder. An excitation wavelength of 295 nm was used to 
primarily excite Trp residues and the emission spectra were collected from 310 to 400 
nm with a step size of 1 nm and a 1 sec integration time. Excitation and emission slits 
were set at 5 nm. Emission spectra were collected every 2.5 °C with a 3 min 
equilibration time over a temperature range of 10 to 40 °C. A buffer baseline was 
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subtracted from each raw emission spectrum. The fluorescence of proteins were 
monitored at their emission maximum and quenched by the progressive addition of 
small aliquots of an acrylamide stock solution prepared in 20 mM citrate phosphate 
buffer, pH 7.0. The ratio of the tryptophan fluorescence intensity in the absence and 
presence of acrylamide was plotted as a function of increasing acrylamide 
concentration to estimate extent of quenching. No corrections were necessary for 
filter effects under these conditions. 
 
5.2.5. Computational Analysis  
Computational assessment of solvent effects on the ultraviolet absorption peaks of 
the three model aromatic residues was performed employing quantum chemical 
calculations.  The molecular structure of the amino acids was sketched in SYBYL9 
and refined to default convergence thresholds via molecular mechanics optimization 
using the Tripos Molecular Forcefield10 and Gasteiger-Marsili charges11.  These 
structures were then subjected to a quantum chemical optimization in Gaussian 0312 
using the B3-LYP13,14 hybrid density functional method and the split valence 6-
31G(p,d) basis set15,16 (all convergence criteria left at default values).  During all 
geometry optimizations, the molecules were presumed to be in their ground electronic 
state, which implies neutral charge and singlet spin configuration. 
The ultraviolet spectrum of each of these systems was predicted computationally 
by the time-dependent density functional method as implemented in Gaussian 0317, 
again using B3-LYP functionals and 6-31G(p,d) basis sets.  Temperature-dependent 
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solvent perturbations of these spectra were modeled with the IEF-PCM method18.  
Default values for all solvation parameters were used, except for the following: 
• Pauling radii were specified for all atoms 
• Solvent temperatures were explicitly specified:  for water, a distinct cal ulation 
was performed at each temperature from 0 – 100 ºC in 5 degree increments;  
• Temperature dependent dielectric constants were specified for each solvent/ T 
instance:  values for water were obtained from the studies of Fernandez et al.19 
• Temperature dependent solvent densities were specified for each solvent / T 
instance:  all were derived from the measurements of Lide and Kehiaian20. 
 
5.3. Results 
5.3.1. Temperature dependent 2nd Derivative UV Shifts of Model Aromatic Residues 
    Figure 5.1 displays the intrinsic effect of pH and temperature on the 2nd d rivative 
ultraviolet absorption spectra of the model aromatic amino acid analogs N-acetyl-L-
phenylalanine ethyl ester, N-acetyl-L-tyrosine ethyl ester and N-acetyl-L-tryptophan 
ethyl ester over a wide range of pH (3-8) and temperature (10-60 °C). The N-
acetylated C-ethyl esterified analogs were selected to eliminate a d/or reduce 
undesired electrostatic interactions of the termini with solvent molecules. Moreover, 
the rigidity introduced to the molecules due to presence of such bulky substitutes 
provides a more realistic simulation of the aromatic side chains as part of pro ein 
peptide backbones.             
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Figure 5.1.The pH and Temperature dependence of the derivative absorbance peaks 
of model amino acids. Spectra were collected at 2.5 °C intervals after a 5 min 
equilibration over the temperature range of 10-60 °C. The model compounds used 
were N-acetyl-L-phenylalanine ethyl ester, N-acetyl-L-tyrosine ethyl ester and N-
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The 2nd derivative spectrum of each model aromatic residue displays three 
distinct absorption peaks. The phenylalanine analog exhibits peaks at ~ 251, 257, and 
264 nm; tyrosine at ~ 267, 274, and 282 nm and tryptophan at ~ 271, 281, and 289 
nm. All derivative peaks show a general linear / quasi linear shift to higher 
wavelengths (i.e., red shifts) as a function of increasing temperature. No significant 
pH dependence is observed over the range examined. To estimate the slopes of the 
temperature dependent peak shifts, the initial linear portion of the data in the range of 
10-35 °C was fitted to a straight line to minimize the slight curvature of the data in 
the non-linear regions at higher temperatures. Since there is no detectable pH 
dependency, data at pH 7.0 was selected for comparison purposes in Table 5.1. The 
data suggests that each of the three aromatic residues and their three deconvoluted 
derivative peaks exhibit different dependencies on solvation effects as manifested by 
different temperature dependent slopes. The magnitudes of the shifts are significant 
since shifts as low as 0.5 nm have been indicative of protein conformational 



























Initial λ (nm) 251.42±0.04 267.13±0.03 271.16±0.02 
Slope x 103 (nm/°C) 7.0 (R2=0.95) 12.4(R2=0.99) 4.8(R2=0.81) 
Peak 2 
Initial λ (nm) 257.71±0.02 274.84±0.01 281.07±0.03 
Slope x 103 (nm/°C) 9.1(R2=0.99) 6.0(R2=0.99) 7.8(R2=0.99) 
Peak 3 
Initial λ (nm) 264.23±0.02 282.68±0.01 289.22±0.02 
Slope x 103 (nm/°C) 10.8(R2=0.99) 7.3(R2=0.99) 10.3(R2=0.99) 
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5.3.2. Origin of the Temperature Dependent Peak Shifts 
A probable source of the observed temperature induced spectral alterations in 
aqueous environments involves the interaction of the aromatic side chains with 
solvent molecules. Observation of the effect of solvent on electronic spectra dates 
back to more than a century ago21. Since then, extensive experimental and 
computational analyses have revealed a variety of solute-solvent interactions 
responsible for alterations of the electronic spectra of absorbing molecules in solution. 
Dipolar (i.e., dielectric effects), dispersive (i.e., van der Waals forces), and short-
range specific interactions (e.g., hydrogen bonding) have all been shown to contribute 
to spectral alterations22. The known temperature dependence of such interactions 
suggests that thermal alterations of solvent physical properties and their effects on the 
solute electronic spectra could potentially be a source of the peak shifts observed. 
Association or dissociation of solute molecules can also affect their electronic 
spectra22. The possibility of such solute effects is, however, unlikely here due to the 
low micro-molar concentrations of the residues employed and the pH independence 
of the temperature dependent data (Fig 5.1).   
 
5.3.3. Computational Analysis  
The origin of the observed spectral alterations was investigated employing 
quantum chemical calculations according to the computational analysis described in 
the method section. For each of the three amino acids, quantum chemical excited state 
calculations resolve the π→π* transition band as a number of discrete states, each of 
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which exhibits a roughly linear dependence on solvation effects, but with significant 
variation in slopes from one state to the next (Fig 5.2). Our calculations do tend to 
systematically overestimate vertical excitation energies (e.g., the leading edge of the 
absorption band for the tryptophan analog is computed to be at 269.98 nm), however 
this is consistent with prior observations on cyclic/polycyclic aromatic compounds23.  
To estimate the effective shift of the observed composite band at a given temperature, 
the weighted average shift was calculated according to: 
 
 
where i indexes specific optically active peaks (i.e., Fi ≠ 0) within the π→π* band, 
∆λi is the shift of peak i at a given T and expressed relative to the peak position for 
the specific solvent of interest at T =  0 °C, Fi is the oscillator strength of peak i at a 
given T, and F is the sum of all oscillator strengths of all peaks within the π→π* 
band.  For the purpose of this computation, the list of peaks in the π→π* band 
included all of those between (and including) the π→π* peak maximum and the 
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Figure 5.2.Different dependence of the multiple discrete states within the π→π* 
transition band on solvation effects manifested by their different temperature 
dependencies. Model compounds used were N-acetyl-L-phenylalanine ethyl ester, N-
acetyl-L-tyrosine ethyl ester, and N-acetyl-L-tryptophan ethyl ester.  
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Quantum chemical calculations provide a detailed characterization of the 
multiple excited states within the π→π* band (Fig 5.2) that collectively lead to the 
overall red shift observed both experimentally (Fig 5.1) and computationally (Fig 5.3). 
The trends observed in Figure 5.3 correspond to the temperature dependent solvent 
shifts averaged over all states, weighted according to the oscillator strength, and are 
within the π→π* band of the spectrum. The trends (i.e., red shifts as a function of 
increasing temperature) obtained from the computational analysis are in agr ement 
with the experimental results. 
The magnitudes of the shifts of the absorbance peak positions, however, are 
smaller than the experimental ones.  A variety of effects may account for this 
discrepancy, of which the greatest probably arises from the differences between the 
heterogeneous interaction profiles in a rigorously explicit solvation system versus the 
time averaged implicit solvent model employed herein.  In an explicitly solvated 
environment, it is reasonable to expect that the solute will influence the relative 
alignments of surrounding solvent molecules in ways that favor and thus enhance the 
polarization trends suggested in the implicit system. Moreover, the vibrational effects 
may also induce a greater solvent effect than is suggested by our static model; 
rigorously testing this prospect would be computationally very challenging due to th



































 N-acetyl-L-Phenylalanine ethyl ester
 N-acetyl-L-Tyrosine ethyl ester
 N-acetyl-L-Tryptophan ethyl ester
 
Figure 5.3.Temperature dependence of the absorbance peaks of model amino acids 
obtained from quantum mechanical analysis over the temperature range of 0-100 °C. 
Model compounds used were N-acetyl-L-phenylalanine ethyl ester, N-acetyl-L-
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Temperature dependent density and dielectric values were the only explicit 
solvent parameters defined in the computational model. Since the temperature 
dependent density alterations showed minor effects (data not shown), the 
computational analysis suggests the temperature dependent dielectric alterations to be 
a major source of the spectral changes observed.  
The relative shifts of the component state vary significantly (some in fact 
show blue shifts) as a result of structural anisotropy within these model system  (Fig 
5.2).  Since each state can be theoretically decomposed into relative contributions 
arising from specific atoms, it could be possible to use incumbent state-specific 
information to predict differences in the solvent effects arising from differences in the 
solvent exposure profiles of amino acids in different environments. 
 
5.3.4. Other Solvent Properties Contributing to the Spectral Alterations Observed 
According to Coulomb’s law, the potential energy between two charges (here 
solute-solvent dipoles) is altered as a function of solvent dielectric constant24. It is 
reasonable to expect that the temperature induced alterations of the solvent dielectric 
constant will be at least a partial source of the spectral alterations observed, as already 
suggested by the computational analysis. The implicit nature of the computational 
analysis, however, fails to reflect differences in the spectroscopic effects arising from 
other solvent physical properties. Thus, essentially all of the effects on the solut
spectra are assigned to temperature dependent dielectric alterations. A variety of 
organic solvents with a range of physical properties were selected to experimentally 
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investigate other solvent properties that might be contributing to the spectral 
alterations observed (Table 5.2)24.  
ε is solvent dielectric constant, π* is the solvent polarizability, α is solvent 
hydrogen donating ability, and β is solvent hydrogen accepting ability. DMSO with a 
high proton accepting ability (large β value) is the model solvent of choice for 
investigating short-range specific interactions (i.e., hydrogen bonding). Methanol and 
acetonitrile are polar organic solvents with considerably lower dielectric properties 
compared to water and are employed here for examining dipolar interactions and 
hexane is a nonpolar solvent suitable for investigating the effect of van der Waals 





















Solvent ε π α β 
DMSO 47 1.0 0.00 0.76 
Methanol 33 0.6 0.93 0.66 
Water 78 1.1 1.17 0.47 
Acetonitrile 36 0.75 0.19 0.40 
Hexane 2 -0.04 0.00 0.00 
 
   Table 5.2.Various solvent scales. ε is solvent dielectric constant, π* is the solvent  
   polarizability, α is solvent hydrogen donating ability, and β is solvent hydrogen    
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To examine whether temperature dependent solvent dielectric changes are the 
dominant contributor to the spectral alterations observed as suggested by the 
computational analysis, mixtures of organic solvents in water were used to mimic 
changes in the dielectric constant of water induced thermally. The dielectric constants 
of the mixtures were estimated as the sum of the mole fraction of each component 
times the dielectric constant of the neat liquid20, 25-27. 
If the spectral alterations observed are due to alterations of the solvent 
dielectric properties alone, then all binary mixtures should produce similar peak shifts 
(i.e., slopes). This was not seen to be the case here, however (Fig 5.4). Mixtures of 
methanol and acetonitrile in water produced similar magnitude of peak shifts for 
phenylalanine and tryptophan residues with the exception of the tyrosine analog 
where larger red shifts were observed as a function of increasing acetonitril  in water. 
The latter is presumably due to the presence of the well known π-π i teractions 
between the acetonitrile cyanide group π orbitals and the phenol ring of the tyrosine 
side chain. The large electron donating ability of the phenol hydroxyl group enhances 
the electron density of the aromatic ring and contributes to the enhanced π-π 
interactions observed. The difference in stabilization energy provided by the 
presumed π-π interactions on the tyrosine ground and excited state explains the red 
shifts observed; the electron donating capability of oxygen to the benzene ring of 
phenol is significantly higher in the excited state compared to the ground state further
strengthening the π-π interactions in the excited state28; the larger stabilization energy 
of the excited state, according to Planck’s law, results in the red shifts observed.       
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Figure 5.4.Shifts of the derivative absorbance peaks of model amino acids as a 
function of solvent dielectric constant. Model compounds used were N-acetyl-L-
phenylalanine ethyl ester, N-acetyl-L-tyrosine ethyl ester, and N-acetyl-L-tryptophan 
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The largest deviations are observed for the DMSO mixtures presumably due 
to its extensive proton accepting ability (Table 5.2). We were unable to collect 
reliable data for the phenylalanine analog in DMSO-water mixtures since DMSO 
absorbs in the same region of the UV spectrum and thus interferes with data 
collection. High resolution data, however, show major differences for the other two 
analogs (Fig 5.4), with more extensive deviations observed for the tyrosine analog. I  
a molecule possessing a hydroxyl group, the direction of the spectral shifts induced 
by hydrogen bond formation depends upon whether the molecule acts as a proton 
donor or acceptor29. If the hydroxyl group acts as proton acceptor, then a blue shift is 
observed whereas if it acts as a proton donor, a red shift occurs as observed here. 
When phenol forms a hydrogen bond with a proton acceptor like DMSO, there occurs 
charge transfer from the nonbonding orbital of DMSO to the O-H antibonding δ* 
orbital, which makes the δ bond of O-H a little weaker. In other words, the electron 
density on the oxygen atom of phenol becomes larger than in the free molecule so 
that the coulomb potential energy of the oxygen 2pπ electrons decreases, resulting in 
a red shift27. In addition, electron transfer from oxygen 2pπ electrons to the benzene 
ring π system is larger in the π-π* excited state than in the ground state. Therefore, the 
charge separation becomes larger in the excited state so that the proton donating 
ability of phenol is increased much more in the excited state compared to ground state. 
This is responsible for the red shifts observed (Planck’s law). 
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5.3.5. Effect of Microenvironment Viscosity 
The extensive deviations observed for the mixtures containing DMSO could 
also potentially be due to its more viscous nature20. The side chains of the aromatic 
residues posses certain levels of rotational and vibrational motion in solution. 
Shapovalov et al.30 have shown that direct correlation exist between the side chain 
capability to posses rotameric states and its electron density in which rotame ic side 
chains posses larger electron densities than non-rotameric ones. Considering the 
nature of the molecular dipolar interactions herein as a major contributor to the 
spectral alterations observed, the reduction of the side chain electron densities should 
result in weaker solute-solvent dipolar interactions. Moreover, according to 
Coulomb’s law, effective interaction of solvent-solute dipoles depends on the 
distance between the two dipoles (i.e., dipoles encountering each other in solution) 
and also on the proper alignment of the dipoles (i.e., the angle between the two 
dipoles). The probability of such effective interactions is expected to be statistically 
enhanced by increasing the mobility of the solute molecules in solution. We therefore 
speculate that the spatial restriction on the microenvironment of the aromatic residues 
due to higher viscosities may be partially responsible for the spectral altertions 
observed.   
To further examine the effect of viscosity on the electronic spectra of the 
model aromatic analogs, mixtures of ethylene glycol in water were used to mimic
changes in the dielectric constant of water induced thermally. Ethylene glycol is 
considerably more viscous than other solvents examined (~ 20 fold more viscous than 
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water)20. With the exception of phenylalanine peak 3, all data show enhanced red 
shifts with increasing ethylene glycol concentration in water confirming the 
restrictive effect of microenvironment viscosity on the electronic spectra of the 
aromatic residues (Fig 5.5).  
The restrictive effects of viscosity is manifested by red shifts in peak osition 
similar to those observed due to the enhanced restrictive effects of hydrogen bondi g 
and π-π interactions on the side chain mobility. The ethylene glycol has similar 
dielectric properties to methanol and both contain a functional hydroxyl group that 
can be involved in possible hydrogen bonding interactions with solute molecules. 
Increasing methanol concentrations in water produced similar red shifts to the ones 
induced thermally (Figure 4), although, ethylene glycol-water mixtures produced 
much larger red shifts, presumably due to the more viscous nature of ethylene glycol 
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Figure 5.5.Shifts in the derivative absorbance peaks of model amino acids as a 
function of dielectric constant.  Model compounds used were N-acetyl-L-
phenylalanine ethyl ester, N-acetyl-L-tyrosine ethyl ester, and N-acetyl-L-tryptophan 
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5.3.6. Effect of Dispersive Interactions 
The temperature dependent spectral alterations of the phenylalanine analog 
were monitored in hexane, a very non polar solvent with much lower dielectric 
constant values than water. Comparable peak shifts were observed in hexane to other 
organic solvents (Fig 5.6). Considering the highly non-polar nature of both solute (i.e., 
the benzene ring of phenylalanine) and the solvent, hexane, apolar interactions are 
expected to be the dominant contributor to the shifts observed. Current computational 
































Figure 5.6.Temperature dependent derivative absorbance peak shifts of N-acetyl-L-
phenylalanine ethyl ester in different organic solvents over the temperature r nge of 
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5.3.7. Effect of Solute-Solvent Interactions on Temperature Dependent Peak Shifts 
To examine the effect of the various solute-solvent interactions discussed here 
on the temperature dependent 2nd derivative UV peak shifts of the aromatic residues, 
the tryptophan and tyrosine analogs were studied in mixtures of DMSO and methanol 
in water.  
The magnitude of the peak shifts of the tryptophan analog decreases in both 
DMSO and methanol mixtures in water with increasing organic solvent concentration 
(Fig 5.7). The data suggest that the slopes of the temperature dependent plots are 
sensitive to the dielectric properties of the solution environment as also supported by 
the computational analysis. Methanol exhibits enhanced effects on the slopes 
compared to DMSO due to its significantly lower dielectric constant values (Table 
5.2). 
The effect of other stabilizing interactions (i.e., hydrogen bonding) was also 
examined by the ability of the DMSO mixtures to alter the temperature depen nt 2nd 
derivative peak shifts of the tyrosine and tryptophan analogs with different proton 
donating abilities to DMSO. (Phenylalanine was not included here due to both DMSO 
absorbance interference and also phenylalanine’s lack of proton donating abilities 
compared to the other two amino acid analogs). The magnitude of the slopes as a 
function of increasing DMSO concentration in water decreases more significantly for 
the tyrosine analog due to more extensive hydrogen bonding between the tyrosine 
side chain and DMSO as discussed earlier (Fig 5.4).  
 


















Figure 5.7.Temperature dependent derivative absorbance peak shifts of model 
aromatic amino acids in different organic solvent mixtures in water over the 
temperature range of    25-60 °C. Model compounds used were N-acetyl-L-tyrosine 
ethyl ester, and N-acetyl-L-tryptophan ethyl ester. (n=2) 
 
 



























 20% DMSO in Water
 50% DMSO in Water
 100% DMSO



























 20% Methanol in Water
 50% Methanol in Water
 100% Methanol 
























 20% DMSO in Water
 100% DMSO 
 - 189 -
5.3.8. Temperature Dependent 2nd Derivative Absorbance Spectroscopy of Aromatic 
Amino Acids in Proteins  
Solvent penetration into protein apolar cores contributes significantly to the 
high polarizability of protein interiors where hydration of the interior results in 
dielectric constant values three to six fold larger than those observed for dry protein 
powders31. Focusing on protein pre-transition region, we have shown both 
experimentally and computationally the sensitivity of the 2nd derivative UV peak 
shifts of the three aromatic residues to thermally induced alterations of the slvent 
dielectric properties. We therefore hypothesize that the temperature dependent 2nd 
derivative UV peak shifts of the aromatic residues in proteins should correlate with 
the hydration of the interior aromatic residues and consequently solvent penetratio  
into the protein core. One major contributor to such solvent penetration is protein 
intramolecular dynamic motions. Thus, we suggest that temperature dependent 
spectral alterations observed should be a qualitative measure of such dynamic 
behavior. 
A direct correlation between the extent of peak shifts (dλ/dT) and the local 
mobility of the aromatic side chains was also investigated in which restrictive factors 
such as hydrogen bonding of the side chains and more viscous microenvironments 
lowered the magnitude of the shifts observed. We therefore further suggest that the 
temperature dependent peak shifts should also correlate with the local dynamic 
motions of the aromatic side chains and that the slopes observed are sensitive to both 
protein global and local dynamic motions. 
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The temperature dependent 2nd derivative UV analysis of the aromatic 
residues was therefore investigated in a variety of model proteins and pepties to test 
this hypothesis (Table 5.3). All proteins examined retained their native conformati n 
in the temperature range of 10-35 °C examined as observed by CD, intrinsic 
fluorescence, and turbidity analysis (data not shown). Azurin, RNase-T1, and protein 
A were selected due to their highly buried tryptophan residues with limited solvent 
accessibility as corroborated by tryptophan peak positions of ~ 319, 323, and 326 nm 





































Protein A 1 60 7.1 0 1 1 
RNase-T1 1 130 14.0 4 10 1 
Azurin 4 128 13.9 6 2 1 
Melittin n.a. 26 2.85 0 0 1 
Leucine 
Enkephaline 
n.a. 5 0.55 1 1 0 
Substance P n.a. 11 1.35 2 0 0 
Angiotensin I n.a. 10 1.3 1 1 0 
HSA 2 584 66.2 31 18 1 
L-Asparaginase 4 326 34.6 8 12 1 
 
  Table 5.3.Physical and chemical properties of proteins studied. 
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The 2nd derivative UV peak position of the tryptophan residue was monitored 
as a function of increasing temperature. The tryptophan analog exhibited the largest 
red shifts followed by melittin, a linear peptide, and then the model globular proteins 
containing highly buried tryptophan residues (Fig 5.8). The dramatic reduction in the 
temperature dependent slopes for the highly buried side chains supports the 
hypothesis that there is a direct correlation between the magnitude of the temperature 
dependent slopes and the extent of side chain hydration. 
To evaluate the applicability of temperature dependent 2nd derivative UV 
spectroscopy of the aromatic residues to the study of protein dynamics, acrylamide 
quenching of the proteins intrinsic fluorescence was employed as a complimentary 
technique for comparison purposes32. Fluorescence acrylamide quenching (Fig 5.8, 
inset) exhibits a similar extent of quenching and therefore comparable dynamic 
motions for RNase-T1 and protein A. The 2nd derivative UV slopes are in agreement 
with the quenching studies in which similar slopes were obtained for the two model 
proteins over the temperature range examined.  
The 2nd derivative absorbance slopes, however, showed larger slopes for 
azurin compared to RNase-T1 in disagreement with the fluorescence acrylamide 
quenching results reported by Eftink et al.32 One possible explanation may be an 
increased sensitivity of the 2nd derivative technique to the local dynamic motions of 
the aromatic side chains, specifically to hydrogen bonding. The indole side chain of 
the tryptophan residue in Azurin is surrounded by a number of nonpolar side chains, 
establishing strong apolar interactions33. In RNase-T1, however, the tryptophan side 
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chain forms a hydrogen bond with a glutamic acid residue in its proximity34. Rueda et 
al.35 show that the rigidifying force constants exerted by hydrogen bonds on protein 
dynamics are much larger (~ 4 fold) than those from apolar interactions. Consideri g 
the sensitivity of the 2nd derivative technique to the local flexibility of the side chains, 
the reversed order of slopes could be explained if the fluorescence technique (i.e., its
excited state) is insensitive to such local dynamic properties.  
One potential major advantage of the 2nd derivative UV absorption technique 
over fluorescence methods is the ability to also examine the phenylalanine and 
tyrosine side chains in addition to tryptophan residues. We therefore also examin d 
the peak shifts of a variety of small linear peptides containing phenylalanine d 





























Figure 5.8.Temperature dependent derivative absorbance peak shifts of the 
tryptophan residue of model proteins over the temperature range of 10-35 °C. Inset 
shows acrylamide quenching of the fluorescence of proteins containing single 
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Figure 5.9 demonstrates agreement between the data obtained for the linear 
peptides with those of the model aromatic analogs. Angiotensin I, however, exhibits 
decreased slopes when examining tyrosine side chain. This again could be explained 
by restricted local motions of the tyrosine side chain when it is involved in hydrogen 
bonding or cation-π interactions with the arginine side chain in its close proximity. 
Such interaction is absent in substance P due to presence of only apolar residues in 
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Figure 5.9.Temperature dependent derivative absorbance peak shifts of tyrosine and 
phenylalanine residues in model peptides over the temperature range of 10-35 °C. 
Model aromatic amino acids used were N-acetyl-L-tyrosine ethyl ester and N-acetyl-
L-phenylalanine ethyl ester. (n=3) 
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To explore the applicability of this approach to phenylalanine and tyrosine 
residues, we examined a variety of model proteins (Table 5.3). The temperature 
dependent shifts of each of the three derivative peaks of either phenylalanine or 
tyrosine vary when monitored for a given model protein (Fig 5.10). This can be 
explained based on the previously described quantum chemical excited state 
calculations from which the main π→π* transition band was resolved into a number 
of discrete states, each of which exhibited a different dependence on solvation effects 
(Fig 5.2). The distinct temperature dependence of each of the three derivative peks 
for a given aromatic residue was further supported through direct experimental 
observations as well (Fig 5.1 & Table 5.1).  
Monitoring temperature dependent peak shifts of phenylalanine and tyrosine 
side chains in a variety of proteins, a general trend of reduced slopes (with a few 
exceptions) for globular proteins with partially to fully buried residues were observed 
(Fig 5.10). This again supports the proposed correlation between the magnitude of the 
observed temperature dependent peak shifts and extent of the hydration of buried 
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Figure 5.10.Temperature dependent derivative absorbance peak shifts of tyrosine and 
phenylalanine residues in model peptides and proteins over the temperature range of 
10-35 °C. Model aromatic amino acids used were N-acetyl-L- rosine ethyl ester and 
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The resolutions obtained from the 2nd derivative UV peak shifts of 
phenylalanine and tyrosine analogs, however, are significantly less than those of 
tryptophan. This is understandable considering the much larger extinction coefficient 
of tryptophan (ε280=5540) compared to tyrosine (ε280=1480) and phenylalanine 
(ε258=197) which results in a better signal to noise ratio for the former
6. Considering 
the local restrictive environmental effects (i.e., hydrogen bonding, π-π interaction, etc.) 
as discussed previously, the presence of a large number of phenylalanine and tyrosie
residues in proteins (Table 5.3) could also contribute by producing a high degree of 
heterogeneity. The abundance of phenylalanine residues, however, is expected to be 
less problematic since they tend to be deeply buried in protein cores, maintaining 
dominantly apolar interactions with surrounding apolar side chains. Tyrosine residues, 
on the other hand, tend to be more dispersed throughout protein three dimensional 
structures, resulting in more heterogeneous microenvironments when present in large
numbers. In addition, the ability of the phenol side chain of tyrosine residues to 
participate in a variety of different interactions with surrounding side chains adds to 
the complexity of their spectroscopic signals.  
 
5.4. Discussion 
Proteins are highly dynamic molecules residing in aqueous environments in 
which both their static and dynamic properties as well as the nature of the 
surrounding environment affects their structure and function. Central questions as to 
how protein dynamics bridge their structure and function, and how environmental 
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factors affect protein dynamical-structural-functional properties have engendered 
great interest. Various protein functions such as substrate binding, product release, 
regulation, allosteric behavior, as well as contractile and motor functions are he vily 
controlled by collective motions within proteins36. Fluctuations of the surrounding 
solvent molecules have been shown to control protein dynamic motions, engendering 
the use of the term “slaving” to describe the significance of the dominant role of 
solvent in controlling protein dynamics and function2.  
Here, we have investigated the applicability of the temperature dependent 2nd 
derivative ultraviolet absorption spectroscopy of the aromatic amino acids to study 
protein dynamics. This technique has been effectively employed for more than two 
decades to study protein conformational changes based on protein static properties 
(e.g., thermal unfolding). In previous applications of this technique, the origin of the
temperature-dependent UV peak shifts in the protein pre-transition regions over 
which proteins retain their native structure has received little or no attention. 
Therefore, the scope of this work was to investigate the physical origin and 
application of such pre-transition alterations.  
This work shows that plots of the temperature dependent 2nd derivative peak 
position of the aromatic residues have measurable quasi-linear slopes below the 
protein’s melting temperature. Both computational and experimental analyses suggest 
that temperature dependent alterations of the solvent’s physical properties and their 
effects on solvent-solute interactions are the source of the spectral changes observed. 
Extensive previous studies have explored the nature of the solvent-solute interactions 
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responsible for alterations of solute electronic spectra in which dipolar, van der Waals, 
and short range specific interactions (e.g., hydrogen bonding) have been shown to be 
major contributors22. Considering the temperature dependence of such interactions, 
they were investigated as potential sources of the spectral changes observed.  
Our computational and experimental results suggest that the spectral 
alterations of the aromatic residues are sensitive to temperature dependent solv t 
dielectric changes. Both the absolute value and magnitude of solvent dielectric 
alterations appear to be important in producing the shifts observed. The largest 
temperature dependent alterations were observed in water which possesses th  highest 
dielectric constant value and the greatest extent of temperature dependent dielectric 
alterations. The magnitude of the experimentally observed peak shifts was reduced 
significantly upon addition of organic solvents to water due to lowering of the solvent 
dielectric constant.  
Based on the origin of spectral alterations observed, we proposed the 
applicability of such information to the study of protein dynamics. Previous studies 
have shown solvent penetration (due to protein global dynamic motions) to be 
responsible for the high polarizabilities and large dielectric constant values obs rved 
in protein interiors31. Considering the sensitivity of the observed temperature 
dependent peak shifts of the aromatic residues to the dielectric properties of th  
surrounding solvent, the utility of the 2nd derivative UV absorption method was 
examined as a qualitative tool to probe protein dynamical motions that at least 
partially control the hydration of buried aromatic residues in protein interiors. The 
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utility of this technique appears plausible when studying model proteins with 
extensive buried tryptophan residues. Model proteins showed considerably reduced 
temperature dependent slopes compared to the tryptophan analog and linear peptides 
with exposed indole moieties.  
The sensitivity of the temperature dependent peak shifts to local dynamic 
motions of aromatic side chains was also investigated in which restrictive forces such 
as hydrogen bonding reduced the magnitude of the peak shifts. Based on this, the 
effect of protein local dynamic motions on temperature dependent peak shifts was 
also evaluated. Complimentary fluorescence acrylamide quenching studies showed 
agreement in dynamic behavior with the UV technique for RNase-T1 and protein A. 
Opposite trends, however, were obtained when comparing RNase-T1 and azurin 
which could be explained by the sensitivity of the UV technique to local rigidifying 
effects (i.e., hydrogen bonding) absent in the fluorescence technique.  
Multiple peptides containing phenylalanine and tyrosine residues were also 
analyzed to demonstrate the advantages of the UV absorbance approach over 
fluorescence techniques in their ability to monitor spectral alterations of 
phenylalanine and tyrosine residues. This data exhibited slopes comparable to the 
model aromatic residues further supporting the applicability of this technique in the 
context of all three aromatic residues. Although the results with proteins supported 
the overall expected trends of reduced slopes compared to amino acid analogs, 
resolution of the data were not as good as those of tryptophan. This is presumably due 
to the much lower extinction coefficients of these residues resulting in poor signal to 
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noise ratios. Furthermore, the presence of large number of these residues that 
collectively contribute to the peak shifts observed provides another source of 
heterogeneity in the data. Future work is intended to investigate small synthetic 
proteins with single phenylalanine and/or tyrosine residues to shed more light on their 
contribution to the temperature dependent UV peak shift dynamics approach.      
 
5.5. Conclusion   
We have investigated the origin and application of the temperature-dependent 
peak shifts of the three aromatic residues in protein pre-transition regions. We 
conclude that such alterations are sensitive to temperature dependent changesof 
solvent physical properties and therefore can be used as a qualitative tool to study 
protein dynamic motions that produce alterations in the hydration of buried aromatic 
residues in protein interiors. We have shown that such alterations are sensitive to both 
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6.1. Overview 
Protein instability is a particularly important issue in the pharmaceutical 
industry as the number of therapeutic protein products continue to increase1. The 
marginal stability associated with many macromolecular-based agents introduces 
significant difficulties in development of proteins and their complexes as safe and 
efficacious therapeutics. Macromolecules, due to their large size and complexity ar  
prone to a variety of physical and chemical degradations during their manufacturing, 
storage, and shipment. This often results in loss of their biological activity and altered 
immunogenicity, jeopardizing their potential benefits to human health2.  
Given this high degree of structural complexity and associated degradation pathways, 
an optimized formulation that retains a protein’s stability and activity over its ntire 
shelf life is crucial. The FDA requires that the stability and activity of potential 
protein therapeutics be demonstrated in real time under the proposed labeled storage 
conditions. Considering the desired long shelf life of therapeutic proteins (18-24 
months) 3, however, these types of studies demand that significant resources be 
dedicated to them for extended periods of time. One time and cost effective approach 
involves conducting accelerated stability studies to identify potential formulations 
with properties that lead to enhanced stability under more moderate storage 
conditions. Such accelerated studies are typically conducted under a variety of 
different stressed conditions (e.g., elevated temperatures, suboptimal pH, high or low 
ionic strengths, etc.) to induce protein degradation over a short period of time.  
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Herein, a rapid and systematic approach has been employed for biophysical 
characterization of complex macromolecular systems under accelerated degra ation 
conditions. The “Empirical phase diagram” (EPD) approach4 employed integrates a 
large library of data obtained from a variety of experimental techniques (e.g., circular 
dichroism, intrinsic and extrinsic fluorescence, static and dynamic light scattering, 
etc.) into an easy-to-visualize color coded map to provide a global picture of protein 
structural response to a wide range of stressed solution conditions.  
 
6.2. Chapter Summaries & Future Works 
6.2.1. Chapter 2 
In chapter 2, the EPD approach was utilized for the characterization of 
recombinant vault particles5-8, a large and complex ribonucleoprotein. With the 
current interest in employing recombinant vaults as nanocapsules for the delivery of 
biomolecules, characterization of the physical stability of vault particles under a 
variety of solution conditions has the potential to provide important information 
concerning vault’s structural integrity and its potential use as drug delivery vehicles. 
Our studies identified ten different conformational states of the vaults over the pH 
and temperature range studied with the most stable region found at pH 6-8 below 
40 °C and the least stable condition at pH 4-6 above 60 °C. A unique intermediate 
molten globule-like state was also identified at pH 6 and ~55 °C. EM imaging 
showed the opening of intact vaults into flower-like structures when transitioning 
from neutral to acidic pH supporting the potential utility of these particles as 
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nanocapsules for drug delivery since one mechanism by which therapeutic agents 
entrapped in vaults could be released is through an opening of the intact vault 
structure. In vivo, naturally occurring vault nanocapsules posses a dynamic structure 
and appear to be highly interactive with their surrounding environment9. Therefore, 
future work should focus on construction of an EPD based on techniques such as 
hydrogen/deuterium exchange, red edge shift spectroscopy, time correlated singl  
photon anisotropy measurements, pressure perturbation calorimetry, and high 
resolution ultrasonic spectroscopy that are more sensitive to the dynamic behavior of 
vault internal structure. 
 
6.2.2. Chapter 3  
In chapter 3, the EPD method was utilized as a rapid and systematic approach 
to pre-formulation studies of a complex fusion cytotoxin composed of mutated 
versions of Interleukin-13 and Pseudomonas Exotoxin A10-13 with the ultimate goal of 
developing a stable liquid formulation. The EPD approach identified apparent phase 
boundaries over which the protein’s degradation pathways were accelerated. One 
such boundary (pH 5, 45 °C) over which the fusion protein showed extensive 
aggregation was used as a basis for the development of a high throughput excipient 
screening assay employing a kinetic-based turbidity assay. The ability of members of 
a large library of Generally Regarded as Safe (GRAS) excipients to inhibit 
aggregation of the fusion protein was examined. Polyanions (dextran sulfate), 
polysaccharides (sucrose, dextrose, lactose, and trehalose), polyols (sorbitol and 
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glycerol), salt (sodium citrate), and detergents (Tween 20 and 80) all inhibited prot in 
aggregation by ~ 25 to 80%. Combinations of more promising stabilizers were tested 
to see if there was an additive or synergistic effect of these compounds on the 
inhibition of protein aggregation. The combination of sodium citrate (≥ 0.1M) with 
sugars or polyols (≥10% w/v) inhibited the aggregation of the fusion protein almost 
completely. To further explore whether the inhibitors of aggregation were also 
stabilizing the structure of the protein, the tertiary structural stability of the fusion 
protein was examined in the presence of the aforementioned combinations. 
Combinations of sodium citrate with dextrose, trehalose, or sorbitol all delayed the 
unfolding of the protein by shifting the Tm values to higher temperatures by ~ 3 to 
6 °C. They were therefore identified as optimal formulation additives for this 
particular fusion cytotoxin. 
In addition to the utility of the EPD approach in providing a thorough in vitro 
characterization of this fusion complex, comparison of the fusion protein’s thermal 
stability to the work of others involving the stability of the individual domains 
suggested that they are strongly correlated and that the toxin domain comprising ~ 
84% of the total mass contributes significantly to the fusion protein structural 
alterations. The fusion protein was shown to undergo an acid-triggered α-h lix 
disruptive event similar to its toxin domain, further adapting an unfolded state with 
strong hydrophobicity at or below pH 4, essential for insertion of fusion cytotoxins 
into endosomal membranes14. These studies showed interaction of this protein with 
polyanions in agreement with the presence of such interactions between the toxin 
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domain and anionic lipids of endosomal membranes, as well as IL-13 with its cell 
surface receptor, IL13Rα2. Therefore, our studies show that the thermal stability of a 
complex fusion protein can at least in some cases be understood in terms of the 
behavior of its individual domains.  
Future work should be directed towards further optimization of the final 
concentrations and combinations of more promising stabilizers identified herein to 
provide a suitable liquid formulation compatible with the protein’s therapeutic 
application and its route of administration. Future studies should be focused on 
evaluating and optimizing parameters such as ionic strength, osmolarity, and viscosity 
of the protein formulation and its integrity over its shelf life upon addition of such 
excipients. In addition, a more thorough thermal characterization of the individual 
domains should help to better understand the effects and contributions of the 
individual domains to the overall thermal stability of the fusion complex. 
 
6.2.3. Chapter 4 
In chapter 4, the EPD approach was used for thermal characterization of three 
reassortant human-bovine rotavirus15 strains with the ultimate goal of developing a 
thermostable vaccine formulation resistant to temperature excursions. The 
biophysical studies employed herein have the potential to provide insight into the 
mechanisms of inactivation as a function of a variety of environmental conditions. 
This provides an opportunity for a more rational and systematic formulation of such 
vaccines based on inhibition of such degradation processes. Thermostable vaccines 
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has major benefits including reducing vaccine wastage, increasing vaccine 
effectiveness, reducing dependency on cold chain supplies and equipment, and 
enabling vaccine delivery to remote populations16.  
Examination of the EPD of the three rotavirus strains revealed distinct 
conformational phases across the pH and temperature range examined. The 
spectroscopic data suggested that all three strains were stable across the pH range of 5 
to 8 below 40 °C. This was also supported by EM image analysis of the virus strains 
in which the presence of intact, triple layer infectious particles were observed. All 
three strains showed a region of minimum stability with perturbed secondary and 
tertiary structures along with the presence of aggregates across the pH range of 5 to 8 
at elevated temperatures above 55 to 60 °C. This is supported by EM analysis at 
70 °C which exhibits extensive aggregation. The onset temperatures at which the 
structural alterations occurred was lowered in a stepwise manner as a function of 
increasing pH for all three strains suggesting reduced virus thermal stability as a 
function of increasing pH. All strains exhibited intermediate phases across the pH 
range of 5 to 8 in the region of ~ 40-60 °C with quite subtle secondary or tertiary 
structural perturbations and the presence of micro-aggregates as manifested by atic 
light scattering data. EM analysis showed larger populations of virus particles with 
partially disrupted outer-layers over these intermediate regions. The empirical hase 
diagram approach did not identify any major thermal stability differences among the 
three strains encouraging the potential use of all three in a single rotavirus vaccine 
formulation.  
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We further employed complementary in vitro activity based studies of the 
distinct conformational states identified by the spectroscopic techniques to provide a 
more meaningful interpretation of such complex moieties and their structural stability 
as it is related to their biological activity. These studies showed that secondary 
structural alterations of the virus complex as well as their agg egation resulted in loss 
of virus activity. Virus activity was shown to be highly pH and temperature 
dependent and varied among the three strains.   
Previous Studies of a variety of vaccine candidates have shown that 
identification of regions of marginal stability in the EPD serve as a basis for the 
development of high throughput screening assays and identification of solution 
stabilizers2,17,18. Therefore, future work should be directed towards developing 
screening assays and the consequent identification of optimized liquiformulations 
containing individual as well as combinations of all three strains in a single 
formulation. 
Comparing to the other two macromolecular systems discussed in Chapters 2 
and 3, the biophysical data obtained for the virus systems were found to be harder to 
interpret due to the more complex nature of this macromolecular system. The results,
however, still can be used to detect stability changes due to the distinctive and highly 
reproducible signals produced. Rotavirus exhibited well defined sizes and shapes 
employing dynamic light scattering. In addition, biophysical techniques such as CD 
and fluorescence generated reproducible results across the pH and temperature range 
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examined. A further significance of such an approach was indicated by analysis of 
virus activity and its relationship to the structural alterations observed herein. 
It should be emphasized that although such accelerated stability studies 
provide a rapid and systematic approach for a thorough biophysical characterization 
of macromolecular complexes under artificially induced degradation conditions, real 
time stability must be directly examined in actual long-term stability studies. This is 
due to the possible presence of different degradation mechanisms under accelerated 
versus more moderate storage conditions19.  
 
6.2.4. Chapter 5 
In addition to the aforementioned structural alterations and aggregation (i.e. 
time averaged or static properties) affecting protein stability, protein dynamics have 
been shown to play a role in controlling their stability and function20. Studies 
involving protein dynamics suggest that analysis of protein flexibility along with their 
static properties is necessary for successful characterization of protein structural 
stability. It follows that the availability of techniques that detect protein structural 
fluctuations is crucial for optimal characterization of macromolecular-based 
therapeutics. In Chapters 2-4, we have presented the EPD approach based on a variety 
of biophysical techniques that are sensitive to conformational alterations and 
aggregation (i.e., static properties) of macromolecules. More recent effortshave 
employed data from spectroscopic techniques sensitive to protein internal motions fr 
construction of empirical phase diagrams that should be more sensitive to transitions 
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involving alterations of protein motions21. Such a dynamic-based approach revealed 
that EPDs constructed from such methods provide information above and beyond that 
obtained by the static approach. As part of efforts to utilize available spectroscopic 
tools for a better understanding of protein dynamic properties, for the first time we 
here examined the utility of temperature dependent UV absorption spectroscopy of 
aromatic residues in protein pre-transition regions to show that information obtained 
from such analyses hold valuable information regarding protein dynamic fluctuations 
(Chapter 5). Our studies showed that plots of the temperature dependent 2nd 
derivative peak positions of the aromatic residues have measurable, quasi-linear 
slopes below the protein’s melting temperature. Our computational and experimental 
results suggested that the spectral alterations of the aromatic residues are s nsitive to 
temperature dependent solvent dielectric changes in which both the absolute value 
and the magnitude of solvent dielectric alterations appear to be important in 
producing the shifts observed. The sensitivity of the temperature dependent peak 
shifts to local dynamic motions of aromatic side chains was also investigated in 
which restrictive forces such as hydrogen bonding were shown to affect the 
magnitude of the peak shifts.  
Previous studies have shown solvent penetration (due to protein global 
dynamic motions) to be responsible for the high polarizabilities and large dielectric 
constant values observed in protein interiors22. Considering the sensitivity of the 
observed temperature dependent peak shifts of the aromatic side chains to the 
dielectric properties of the surrounding solvent, the utility of the 2nd derivative UV 
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absorption method was examined as a qualitative tool to probe protein dynamic 
motions that at least partially control the hydration of buried aromatic residues in 
protein interiors. The utility of this technique appeared promising when studying 
model proteins with extensively buried tryptophan residues. Model proteins showed 
considerably reduced temperature dependent slopes compared to the tryptophan 
analog and linear peptides with exposed indole moieties.  
Multiple peptides and proteins containing phenylalanine and tyrosine residues 
were also analyzed to demonstrate the advantages of the UV absorbance approach 
over fluorescence techniques in their ability to monitor spectral alterations of 
phenylalanine and tyrosine residues. Although the results with proteins supported the 
overall expected trends of reduced slopes compared to amino acid analogs, resolution 
of the data was not as good as those of tryptophan, presumably due to the much lower 
extinction coefficients of these residues which resulted in poor signal to noise ratios23. 
Furthermore, the presence of large numbers of these residues that collectively 
contribute to the peak shifts observed provided another source of heterogeneity in the 
data. Future work is intended to investigate small synthetic proteins with single 
phenylalanine and/or tyrosine residues to shed more light on their contribution to the 
temperature dependent UV peak shift dynamics approach.      
In summary, we have employed a rapid and systematic approach employing 
accelerated degradation conditions referred to as the “Empirical phase diagram” (EPD) 
approach to characterize the structural stability of three complex macromolecular 
systems; a large recombinant ribonucleoprotein (chapter 2), a novel multi-domain 
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fusion cytotoxin (chapter 3), and a live-attenuated double stranded RNA virus 
(chapter 4). This approach utilizes advanced algebraic procedures to integrate a la ge 
library of data obtained from a variety of biophysical techniques into an easy-to-
interpret color coded map to provide a global picture of protein structural behavior 
under a wide range of solution conditions. We demonstrate the ability of this 
approach in providing a thorough in vitro characterization of large and complex 
macromolecular systems. We further show the utility of the EPD approach in 
designing high throughput screening assays for identification of solution stabilizers 
and its use in interpretation of the biological activity and function of these systms in 
vivo.  In contrast to simple macromolecules, the more complex systems such as those 
examined here, the measured stability is presumably the sum of all components. This 
can make interpretations at the molecular level somewhat difficult. We show that 
employing the EPD approach, the structural stability of the complex macromolecular 
systems can at least partially be explained in terms of the behavior of their individual 
domains and components.  
Empirical phase diagrams constructed based on techniques sensitive to 
transitions due to alterations of protein motions (i.e., dynamic-based EPDs) have been 
shown to provide information above and beyond that obtained by the static approach. 
Therefore, integration of techniques that detect extensive and subtle conformational 
alterations of proteins, as well as structural fluctuations into an empirical phase 
diagram is beneficial. Herein, we have for the first time examined the temperature 
dependent UV absorption spectroscopy of aromatic residues in protein pre-transition 
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regions (chapter 5). We show that such analyses hold valuable information regarding 
protein dynamic fluctuations which can essentially be integrated into dynamic-based 
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